Joselito C Cabaccan, MD
Endocrinology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Good Samaritan Hospital · Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cabaccan’s office at (408) 223-7000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A78885 · Current
Licensed to practise in California · since 2002 · expires 2028-05-31 · University of Virginia School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$1,888,312
Medicare paid this office $1,888,312 for 2,206 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, romosozumab-aqqg, 1 mg | 58 | $498,770 | None |
| Return visit (30+ min) | 1,515 | $362,431 | $99 |
| Injection, denosumab, 1 mg | 174 | $305,544 | None |
| Short return visit (20+ min) | 1,270 | $146,160 | $70 |
| Ultrasound scan of head and neck soft tissue | 529 | $58,141 | $100 |
See all 48 services
| Injection, romosozumab-aqqg, 1 mg | 58 | $498,770 | None |
| Return visit (30+ min) | 1,515 | $362,431 | $99 |
| Injection, denosumab, 1 mg | 174 | $305,544 | None |
| Short return visit (20+ min) | 1,270 | $146,160 | $70 |
| Ultrasound scan of head and neck soft tissue | 529 | $58,141 | $100 |
| Parathormone (parathyroid hormone) level | 604 | $47,124 | $40 |
| Vitamin d-3 level | 603 | $32,781 | $29 |
| New patient visit (45+ min) | 236 | $30,888 | $131 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 1,285 | $29,492 | $13 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 171 | $27,515 | $116 |
| Blood test, thyroid stimulating hormone (tsh) | 854 | $24,377 | $16 |
| Influenza vaccine, inactivated | 291 | $23,810 | $82 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 354 | $22,534 | $64 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 99 | $22,395 | $39 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 44 | $20,385 | $64 |
| Insertion of needle into vein for collection of blood sample | 1,157 | $20,137 | $9 |
| Hemoglobin a1c level | 852 | $18,021 | $10 |
| Administration of influenza virus vaccine | 442 | $17,582 | $39 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 263 | $15,705 | $28 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $14,007 | $139 |
| Influenza vaccine split virus, preservative free | 159 | $13,083 | $81 |
| Thyroxine (thyroid chemical), free | 849 | $12,924 | $9 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 100 | $11,571 | $63 |
| Injection of drug or substance under skin or into muscle | 293 | $9,560 | $12 |
| Blood glucose (sugar) test performed by hand-held instrument | 992 | $7,582 | $3 |
| Thyroid hormone, t3 measurement, free | 181 | $5,976 | $17 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 95 | $5,613 | $59 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $4,968 | $276 |
| New patient visit (30+ min) | 54 | $4,962 | $92 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 70 | $4,542 | $50 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 29 | $4,516 | $146 |
| Urine microalbumin (protein) level | 482 | $3,821 | $6 |
| Long return visit (40+ min) | 27 | $3,664 | $126 |
| Creatinine level to test for kidney function or muscle injury | 471 | $3,358 | $5 |
| New patient visit (60+ min) | 13 | $2,269 | $175 |
| Thyroglobulin (thyroid protein) antibody measurement | 74 | $2,151 | $16 |
| Injection, zoledronic acid, 1 mg | 89 | $2,026 | None |
| Urinalysis, manual test | 390 | $1,906 | $3 |
| Thyroglobulin (thyroid related hormone) level | 55 | $1,857 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,723 | $96 |
| Pneumococcal vaccine, 23-valent | 13 | $1,700 | $131 |
| Influenza vaccine, trivalent derived from recombinant dna | 18 | $1,473 | $82 |
| Administration of pneumococcal vaccine | 23 | $899 | $39 |
| Cortisol (hormone) measurement, total | 42 | $735 | $16 |
| Hormonal panel for adrenal gland assessment (adrenal gland insufficiency) | 16 | $543 | $32 |
| Short return visit | 12 | $451 | $35 |
| Influenza vaccine, trivalent derived from cell cultures | 11 | $397 | $36 |
| Injection, cosyntropin, 0.25 mg | 14 | $249 | None |
Who their Medicare patients are
2,206 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 14% · Women 67% · Also on Medicaid 54% · Health risk score 1.48. Above the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 64% · Chronic kidney disease 37% · Coronary heart disease 29% · Atrial fibrillation 17% · Heart failure 15% · Cancer 12% · Depression 12% · Dementia 11% · COPD 10% · Stroke 9%.
The office billed $4,092,785, Medicare allowed $2,390,992 and paid $1,888,312; for 112,619 services of 61 kinds; $886,442 of it was for drugs given in the office and $1,001,870 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,206 | 112,619 | 75 | 1.48 | $4,092,785 | $1,888,312 |
| 2023 | 2,081 | 105,008 | 75 | 1.48 | $3,858,652 | $1,715,055 |
| 2022 | 1,938 | 93,128 | 75 | 1.47 | $3,418,331 | $1,463,820 |
| 2021 | 1,824 | 61,913 | 75 | 1.47 | $2,884,663 | $1,272,248 |
| 2020 | 1,665 | 31,640 | 74 | 1.57 | $2,002,141 | $834,465 |
| 2019 | 1,823 | 26,870 | 74 | 1.59 | $1,850,602 | $763,863 |
| 2018 | 1,710 | 23,160 | 74 | 1.56 | $1,746,386 | $690,763 |
| 2017 | 1,633 | 20,293 | 73 | 1.51 | $1,646,027 | $662,588 |
| 2016 | 1,528 | 16,771 | 73 | 1.49 | $1,422,006 | $578,268 |
| 2015 | 1,499 | 14,795 | 73 | 1.55 | $1,361,485 | $543,386 |
| 2014 | 1,653 | 16,413 | 73 | 1.43 | $1,529,089 | $620,431 |
| 2013 | 1,611 | 18,711 | 73 | 1.63 | $1,632,257 | $707,228 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 43 services
| Injection, romosozumab-aqqg, 1 mg | 55 | $455,212 | None |
| Return visit (30+ min) | 1,415 | $361,098 | $106 |
| Injection, denosumab, 1 mg | 165 | $259,609 | None |
| Short return visit (20+ min) | 1,220 | $150,788 | $73 |
| Ultrasound scan of head and neck soft tissue | 495 | $57,224 | $107 |
| Parathormone (parathyroid hormone) level | 528 | $41,299 | $40 |
| New patient visit (45+ min) | 214 | $30,050 | $140 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 170 | $29,898 | $128 |
| Vitamin d-3 level | 518 | $28,894 | $29 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 83 | $21,317 | $42 |
| Influenza vaccine split virus, preservative free | 290 | $20,860 | $72 |
| Blood test, thyroid stimulating hormone (tsh) | 716 | $20,657 | $16 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 50 | $19,881 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 108 | $18,867 | $66 |
| Insertion of needle into vein for collection of blood sample | 1,038 | $17,371 | $8 |
| Hemoglobin a1c level | 811 | $16,117 | $10 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 246 | $15,145 | $30 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $13,509 | $145 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 184 | $12,129 | $66 |
| Administration of influenza virus vaccine | 310 | $11,600 | $37 |
| Thyroxine (thyroid chemical), free | 712 | $10,917 | $9 |
| Injection of drug or substance under skin or into muscle | 280 | $10,779 | $13 |
| Blood glucose (sugar) test performed by hand-held instrument | 1,014 | $8,744 | $3 |
| New patient visit (30+ min) | 81 | $7,379 | $91 |
| Thyroid hormone, t3 measurement, free | 161 | $5,345 | $17 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 68 | $4,954 | $53 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 30 | $4,928 | $149 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 76 | $4,810 | $63 |
| Long return visit (40+ min) | 27 | $3,967 | $147 |
| Urine microalbumin (protein) level | 417 | $3,334 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $2,975 | $96 |
| Creatinine level to test for kidney function or muscle injury | 412 | $2,951 | $5 |
| Injection, zoledronic acid, 1 mg | 79 | $2,314 | None |
| Thyroglobulin (thyroid protein) antibody measurement | 61 | $1,902 | $16 |
| Thyroglobulin (thyroid related hormone) level | 58 | $1,857 | $16 |
| Pneumococcal vaccine, 23-valent | 13 | $1,700 | $131 |
| New patient visit (60+ min) | 11 | $1,682 | $153 |
| Urinalysis, manual test | 274 | $1,398 | $3 |
| Cortisol (hormone) measurement, total | 40 | $703 | $16 |
| Administration of pneumococcal vaccine | 15 | $560 | $37 |
| Short return visit | 13 | $419 | $32 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 11 | $368 | $33 |
| Injection, cosyntropin, 0.25 mg | 12 | $238 | None |
2022: 43 services
| Injection, romosozumab-aqqg, 1 mg | 45 | $378,917 | None |
| Return visit (30+ min) | 1,177 | $274,776 | $99 |
| Injection, denosumab, 1 mg | 161 | $239,294 | None |
| Short return visit (20+ min) | 1,168 | $156,801 | $72 |
| Ultrasound scan of head and neck soft tissue | 427 | $49,996 | $108 |
| Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial | 12 | $36,628 | None |
| Parathormone (parathyroid hormone) level | 435 | $34,159 | $41 |
| Vitamin d-3 level | 436 | $23,885 | $29 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 138 | $22,738 | $131 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 343 | $22,327 | $65 |
| Blood test, thyroid stimulating hormone (tsh) | 640 | $18,344 | $17 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 246 | $16,910 | $68 |
| New patient visit (45+ min) | 123 | $16,331 | $133 |
| Hemoglobin a1c level | 761 | $15,635 | $10 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $14,233 | $164 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 23 | $13,688 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $13,503 | $61 |
| New patient visit (30+ min) | 143 | $12,775 | $89 |
| Injection of drug or substance under skin or into muscle | 289 | $11,041 | $13 |
| Administration of influenza virus vaccine | 292 | $10,982 | $37 |
| Thyroxine (thyroid chemical), free | 630 | $9,496 | $9 |
| Blood glucose (sugar) test performed by hand-held instrument | 916 | $8,566 | $3 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 60 | $5,951 | $33 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 125 | $5,899 | $30 |
| Insertion of needle into vein for collection of blood sample | 908 | $5,226 | $3 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 34 | $5,206 | $153 |
| Thyroid hormone, t3 measurement, free | 158 | $4,655 | $17 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 69 | $4,562 | $65 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 57 | $3,879 | $54 |
| Influenza vaccine split virus, preservative free | 47 | $3,221 | $69 |
| Urine microalbumin (protein) level | 351 | $2,805 | $6 |
| Creatinine level to test for kidney function or muscle injury | 353 | $2,527 | $5 |
| Long return visit (40+ min) | 17 | $2,359 | $139 |
| Injection, zoledronic acid, 1 mg | 71 | $1,815 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,764 | $84 |
| Thyroglobulin (thyroid protein) antibody measurement | 54 | $1,666 | $16 |
| Urinalysis, manual test | 340 | $1,619 | $3 |
| Pneumococcal vaccine, 23-valent | 12 | $1,580 | $132 |
| Thyroglobulin (thyroid related hormone) level | 39 | $1,430 | $16 |
| Administration of pneumococcal vaccine | 16 | $715 | $38 |
| Hormonal panel for adrenal gland assessment (adrenal gland insufficiency) | 18 | $645 | $32 |
| Injection, cosyntropin, 0.25 mg | 19 | $424 | None |
| Cortisol (hormone) measurement, total | 22 | $401 | $16 |
2021: 44 services
| Return visit (30+ min) | 1,282 | $373,657 | $104 |
| Injection, denosumab, 1 mg | 164 | $214,150 | None |
| Injection, romosozumab-aqqg, 1 mg | 26 | $160,880 | None |
| Short return visit (20+ min) | 931 | $121,695 | $76 |
| Ultrasound scan of head and neck soft tissue | 385 | $46,574 | $114 |
| Parathormone (parathyroid hormone) level | 426 | $36,615 | $41 |
| New patient visit (45+ min) | 203 | $27,941 | $138 |
| Vitamin d-3 level | 446 | $25,693 | $30 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 138 | $23,223 | $130 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 325 | $21,811 | $67 |
| Blood test, thyroid stimulating hormone (tsh) | 675 | $20,546 | $17 |
| Hemoglobin a1c level | 798 | $17,509 | $10 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 255 | $16,742 | $65 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 23 | $11,460 | $60 |
| Thyroxine (thyroid chemical), free | 668 | $10,788 | $9 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,163 | $172 |
| Blood glucose (sugar) test performed by hand-held instrument | 915 | $9,644 | $3 |
| Injection of drug or substance under skin or into muscle | 281 | $9,251 | $13 |
| New patient visit (30+ min) | 77 | $7,405 | $96 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 35 | $6,091 | $160 |
| Insertion of needle into vein for collection of blood sample | 933 | $5,724 | $3 |
| Administration of influenza virus vaccine | 247 | $5,430 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,424 | $62 |
| Thyroid hormone, t3 measurement, free | 175 | $5,387 | $17 |
| Long return visit (40+ min) | 30 | $4,542 | $142 |
| Pneumococcal vaccine, 23-valent | 35 | $4,359 | $121 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 55 | $4,171 | $74 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 47 | $3,635 | $55 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 31 | $3,248 | $33 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 76 | $3,063 | $30 |
| Urine microalbumin (protein) level | 356 | $2,826 | $6 |
| Pneumococcal vaccine, 13-valent | 11 | $2,599 | $236 |
| Creatinine level to test for kidney function or muscle injury | 355 | $2,533 | $5 |
| Injection, zoledronic acid, 1 mg | 58 | $2,115 | None |
| New patient visit (60+ min) | 11 | $1,900 | $173 |
| Thyroglobulin (thyroid protein) antibody measurement | 54 | $1,671 | $16 |
| Urinalysis, manual test | 325 | $1,531 | $3 |
| Thyroglobulin (thyroid related hormone) level | 39 | $1,445 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,445 | $85 |
| Administration of pneumococcal vaccine | 41 | $978 | $22 |
| Short return visit | 12 | $910 | $54 |
| Hormonal panel for adrenal gland assessment (adrenal gland insufficiency) | 18 | $620 | $33 |
| Injection, cosyntropin, 0.25 mg | 22 | $566 | None |
| Cortisol (hormone) measurement, total | 24 | $554 | $16 |
2020: 40 services
| Return visit (30+ min) | 1,190 | $290,515 | $85 |
| Injection, denosumab, 1 mg | 81 | $102,443 | None |
| Short return visit (20+ min) | 732 | $70,557 | $59 |
| Ultrasound scan of head and neck soft tissue | 347 | $39,743 | $108 |
| Parathormone (parathyroid hormone) level | 386 | $31,146 | $41 |
| Pneumococcal vaccine, 13-valent | 133 | $29,605 | $223 |
| New patient visit (45+ min) | 182 | $24,412 | $134 |
| Vitamin d-3 level | 430 | $23,399 | $29 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 307 | $20,919 | $67 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 116 | $18,681 | $121 |
| Blood test, thyroid stimulating hormone (tsh) | 586 | $16,996 | $17 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 278 | $16,949 | $61 |
| Hemoglobin a1c level | 763 | $15,676 | $10 |
| Pneumococcal vaccine, 23-valent | 123 | $14,673 | $118 |
| Thyroxine (thyroid chemical), free | 586 | $9,045 | $9 |
| Blood glucose (sugar) test performed by hand-held instrument | 874 | $8,778 | $3 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 45 | $7,424 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,352 | $175 |
| Injection of drug or substance under skin or into muscle | 220 | $6,584 | $13 |
| Administration of influenza virus vaccine | 266 | $5,567 | $21 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 23 | $5,359 | $57 |
| Administration of pneumococcal vaccine | 195 | $5,148 | $21 |
| Insertion of needle into vein for collection of blood sample | 824 | $4,850 | $3 |
| New patient visit (60+ min) | 31 | $4,643 | $150 |
| Thyroid hormone, t3 measurement, free | 120 | $3,692 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $3,091 | $64 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 45 | $3,036 | $54 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 42 | $3,030 | $72 |
| New patient visit (30+ min) | 36 | $3,003 | $83 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 77 | $2,630 | $30 |
| Urine microalbumin (protein) level | 327 | $2,425 | $6 |
| Creatinine level to test for kidney function or muscle injury | 328 | $2,175 | $5 |
| Long return visit (40+ min) | 16 | $1,886 | $118 |
| Injection, zoledronic acid, 1 mg | 44 | $1,689 | None |
| Urinalysis, manual test | 317 | $1,412 | $3 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $970 | $35 |
| Thyroglobulin (thyroid protein) antibody measurement | 34 | $916 | $16 |
| Thyroglobulin (thyroid related hormone) level | 21 | $718 | $16 |
| Injection, cosyntropin, 0.25 mg | 14 | $524 | None |
| Hormonal panel for adrenal gland assessment (adrenal gland insufficiency) | 13 | $485 | $32 |
2019: 39 services
| Return visit (30+ min) | 1,243 | $272,522 | $88 |
| Short return visit (20+ min) | 946 | $87,183 | $60 |
| Injection, denosumab, 1 mg | 60 | $69,230 | None |
| Ultrasound scan of head and neck soft tissue | 401 | $45,087 | $105 |
| Parathormone (parathyroid hormone) level | 373 | $29,211 | $45 |
| Vitamin d-3 level | 447 | $24,882 | $32 |
| Blood test, thyroid stimulating hormone (tsh) | 679 | $20,972 | $18 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 302 | $19,335 | $63 |
| Hemoglobin a1c level | 828 | $19,323 | $11 |
| New patient visit (45+ min) | 131 | $17,174 | $131 |
| New patient visit (60+ min) | 97 | $16,504 | $170 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 115 | $15,696 | $115 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 85 | $14,137 | $149 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 215 | $11,856 | $55 |
| Thyroxine (thyroid chemical), free | 676 | $11,136 | $10 |
| Long return visit (40+ min) | 70 | $9,735 | $120 |
| Blood glucose (sugar) test performed by hand-held instrument | 934 | $8,889 | $3 |
| New patient visit (30+ min) | 95 | $8,353 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $7,527 | $171 |
| Injection of drug or substance under skin or into muscle | 171 | $5,775 | $14 |
| Insertion of needle into vein for collection of blood sample | 915 | $4,945 | $3 |
| Thyroid hormone, t3 measurement, free | 143 | $4,555 | $18 |
| Administration of influenza virus vaccine | 215 | $4,512 | $21 |
| Pneumococcal vaccine, 13-valent | 19 | $4,140 | $207 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 26 | $3,303 | $56 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 98 | $3,001 | $29 |
| Urine microalbumin (protein) level | 339 | $2,724 | $6 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 42 | $2,684 | $52 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 40 | $2,624 | $64 |
| Creatinine level to test for kidney function or muscle injury | 339 | $2,432 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,794 | $62 |
| Injection, zoledronic acid, 1 mg | 41 | $1,642 | None |
| Thyroglobulin (thyroid protein) antibody measurement | 42 | $1,403 | $17 |
| Urinalysis, manual test | 275 | $1,183 | $3 |
| Thyroglobulin (thyroid related hormone) level | 28 | $1,136 | $17 |
| Injection, cosyntropin, 0.25 mg | 18 | $560 | None |
| Administration of pneumococcal vaccine | 26 | $554 | $21 |
| Hormonal panel for adrenal gland assessment (adrenal gland insufficiency) | 15 | $533 | $36 |
| Cortisol (hormone) measurement, total | 17 | $337 | $18 |
2018: 36 services
| Return visit (30+ min) | 1,205 | $241,185 | $79 |
| Short return visit (20+ min) | 872 | $73,231 | $57 |
| Injection, denosumab, 1 mg | 49 | $54,830 | None |
| Ultrasound scan of head and neck soft tissue | 346 | $36,770 | $99 |
| Parathormone (parathyroid hormone) level | 350 | $33,363 | $50 |
| Vitamin d-3 level | 462 | $30,414 | $36 |
| Blood test, thyroid stimulating hormone (tsh) | 629 | $21,673 | $20 |
| Hemoglobin a1c level | 800 | $20,929 | $12 |
| New patient visit (45+ min) | 161 | $19,084 | $119 |
| Fine needle aspiration using imaging guidance | 99 | $18,729 | $124 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 285 | $13,924 | $49 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 86 | $12,678 | $138 |
| Thyroxine (thyroid chemical), free | 625 | $11,511 | $11 |
| New patient visit (60+ min) | 67 | $10,757 | $161 |
| Influenza vaccine split virus, preservative free | 177 | $9,201 | $52 |
| Injection of drug or substance under skin or into muscle | 182 | $8,206 | $17 |
| Blood glucose (sugar) test performed by hand-held instrument | 888 | $8,164 | $3 |
| Ultrasonic guidance for needle placement | 100 | $6,059 | $51 |
| New patient visit (30+ min) | 66 | $5,654 | $86 |
| Administration of influenza virus vaccine | 199 | $5,120 | $26 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,920 | $154 |
| Insertion of needle into vein for collection of blood sample | 830 | $4,533 | $3 |
| Thyroid hormone, t3 measurement, free | 117 | $4,367 | $21 |
| Urine microalbumin (protein) level | 322 | $3,046 | $7 |
| Creatinine level to test for kidney function or muscle injury | 322 | $2,724 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 40 | $2,718 | $68 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 83 | $2,360 | $28 |
| Injection, zoledronic acid, 1 mg | 40 | $2,002 | None |
| Long return visit (40+ min) | 15 | $1,830 | $114 |
| Pneumococcal vaccine, 23-valent | 13 | $1,478 | $106 |
| Thyroglobulin (thyroid protein) antibody measurement | 36 | $1,425 | $19 |
| Thyroglobulin (thyroid related hormone) level | 31 | $1,321 | $19 |
| Urinalysis, manual test | 161 | $781 | $3 |
| Administration of pneumococcal vaccine | 23 | $618 | $26 |
| Cortisol (hormone) measurement, total | 16 | $493 | $20 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 25 | $466 | $19 |
2017: 32 services
| Return visit (30+ min) | 1,107 | $223,730 | $79 |
| Short return visit (20+ min) | 748 | $60,536 | $53 |
| Parathormone (parathyroid hormone) level | 402 | $41,455 | $55 |
| Injection, denosumab, 1 mg | 42 | $41,283 | None |
| Ultrasound scan of head and neck soft tissue | 365 | $39,356 | $99 |
| Vitamin d-3 level | 472 | $34,589 | $40 |
| Fine needle aspiration using imaging guidance | 118 | $24,296 | $123 |
| Blood test, thyroid stimulating hormone (tsh) | 626 | $24,241 | $23 |
| Hemoglobin a1c level | 775 | $22,515 | $13 |
| New patient visit (45+ min) | 183 | $21,105 | $115 |
| Thyroxine (thyroid chemical), free | 626 | $12,993 | $12 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 273 | $12,950 | $47 |
| Influenza vaccine split virus, preservative free | 228 | $11,003 | $48 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 64 | $9,562 | $145 |
| New patient visit (60+ min) | 58 | $9,290 | $160 |
| Injection of drug or substance under skin or into muscle | 163 | $9,012 | $22 |
| Administration of influenza virus vaccine | 250 | $8,105 | $32 |
| Blood glucose (sugar) test performed by hand-held instrument | 869 | $7,690 | $3 |
| Ultrasonic guidance for needle placement | 120 | $7,459 | $51 |
| New patient visit (30+ min) | 60 | $5,033 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,545 | $152 |
| Insertion of needle into vein for collection of blood sample | 795 | $4,278 | $3 |
| Thyroid hormone, t3 measurement, free | 106 | $4,214 | $23 |
| Urine microalbumin (protein) level | 267 | $2,650 | $8 |
| Creatinine level to test for kidney function or muscle injury | 268 | $2,381 | $7 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 57 | $1,956 | $33 |
| Thyroglobulin (thyroid protein) antibody measurement | 37 | $1,541 | $21 |
| Thyroglobulin (thyroid related hormone) level | 26 | $1,318 | $21 |
| Cortisol (hormone) measurement, total | 25 | $986 | $22 |
| Urinalysis, manual test | 136 | $662 | $3 |
| Injection, cosyntropin, 0.25 mg | 18 | $605 | None |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 24 | $429 | $18 |
2016: 34 services
| Return visit (30+ min) | 1,027 | $211,594 | $83 |
| Short return visit (20+ min) | 731 | $61,457 | $57 |
| Ultrasound scan of head and neck soft tissue | 321 | $36,450 | $104 |
| Parathormone (parathyroid hormone) level | 344 | $35,050 | $55 |
| Vitamin d-3 level | 424 | $30,114 | $40 |
| New patient visit (45+ min) | 176 | $22,363 | $127 |
| Blood test, thyroid stimulating hormone (tsh) | 602 | $22,318 | $22 |
| Hemoglobin a1c level | 723 | $21,034 | $13 |
| Injection, denosumab, 1 mg | 30 | $20,882 | None |
| Fine needle aspiration using imaging guidance | 86 | $17,063 | $125 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 292 | $14,411 | $49 |
| Thyroxine (thyroid chemical), free | 594 | $11,838 | $12 |
| New patient visit (60+ min) | 48 | $7,420 | $155 |
| Influenza vaccine split virus, preservative free | 163 | $6,850 | $41 |
| Blood glucose (sugar) test performed by hand-held instrument | 779 | $6,582 | $3 |
| Injection of drug or substance under skin or into muscle | 128 | $6,304 | $22 |
| Administration of influenza virus vaccine | 195 | $6,003 | $30 |
| Ultrasonic guidance for needle placement | 82 | $5,372 | $54 |
| Thyroid hormone, t3 measurement, free | 101 | $4,228 | $23 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 28 | $4,137 | $148 |
| New patient visit (30+ min) | 47 | $4,124 | $88 |
| Insertion of needle into vein for collection of blood sample | 732 | $3,901 | $3 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,289 | $164 |
| Long return visit (40+ min) | 17 | $1,925 | $107 |
| Urine microalbumin (protein) level | 203 | $1,897 | $8 |
| Creatinine level to test for kidney function or muscle injury | 200 | $1,679 | $7 |
| Thyroglobulin (thyroid protein) antibody measurement | 36 | $1,253 | $21 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 31 | $1,032 | $33 |
| Thyroglobulin (thyroid related hormone) level | 21 | $879 | $21 |
| Urinalysis, manual test | 91 | $423 | $3 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 22 | $393 | $18 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 17 | $317 | $19 |
| Cortisol (hormone) measurement, total | 11 | $283 | $22 |
| Blood glucose (sugar) level | 45 | $236 | $5 |
2015: 35 services
| Return visit (30+ min) | 1,029 | $206,522 | $84 |
| Short return visit (20+ min) | 679 | $60,486 | $58 |
| Ultrasound scan of head and neck soft tissue | 298 | $33,436 | $106 |
| Parathormone (parathyroid hormone) level | 332 | $31,764 | $55 |
| New patient visit (45+ min) | 186 | $25,127 | $135 |
| Blood test, thyroid stimulating hormone (tsh) | 637 | $23,508 | $22 |
| Fine needle aspiration using imaging guidance | 110 | $21,572 | $130 |
| Hemoglobin a1c level | 688 | $18,894 | $13 |
| Vitamin d-3 level | 249 | $13,107 | $39 |
| New patient visit (60+ min) | 74 | $12,739 | $172 |
| Thyroxine (thyroid chemical), free | 634 | $12,537 | $12 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 199 | $10,073 | $50 |
| Ultrasonic guidance for needle placement | 113 | $7,227 | $54 |
| Administration of influenza virus vaccine | 213 | $6,773 | $32 |
| Injection, denosumab, 1 mg | 12 | $6,079 | None |
| Injection of drug or substance under skin or into muscle | 89 | $5,341 | $23 |
| Blood glucose (sugar) test performed by hand-held instrument | 645 | $5,114 | $3 |
| Thyroid hormone, t3 measurement, free | 121 | $4,721 | $23 |
| Insertion of needle into vein for collection of blood sample | 818 | $4,484 | $3 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 24 | $4,180 | $155 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,859 | $168 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 165 | $2,954 | $18 |
| Long return visit (40+ min) | 26 | $2,937 | $109 |
| New patient visit (30+ min) | 30 | $2,660 | $89 |
| Urine microalbumin (protein) level | 206 | $1,820 | $8 |
| Dxa bone density measurement of hip, pelvis, spine | 35 | $1,816 | $52 |
| Creatinine level to test for kidney function or muscle injury | 204 | $1,622 | $7 |
| Short return visit | 38 | $1,517 | $37 |
| Blood glucose (sugar) level | 105 | $1,355 | $5 |
| Influenza vaccine, trivalent derived from cell cultures | 48 | $1,048 | $22 |
| Thyroglobulin (thyroid protein) antibody measurement | 22 | $955 | $21 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 22 | $838 | $36 |
| Thyroglobulin (thyroid related hormone) level | 14 | $750 | $21 |
| Cortisol (hormone) measurement, total | 13 | $413 | $22 |
| Urinalysis, manual test | 82 | $321 | $3 |
2014: 35 services
| Return visit (30+ min) | 1,100 | $226,886 | $84 |
| Short return visit (20+ min) | 748 | $70,324 | $58 |
| Ultrasound scan of head and neck soft tissue | 334 | $39,933 | $112 |
| New patient visit (45+ min) | 279 | $37,585 | $135 |
| Parathormone (parathyroid hormone) level | 349 | $35,812 | $55 |
| Fine needle aspiration using imaging guidance | 122 | $27,668 | $130 |
| Blood test, thyroid stimulating hormone (tsh) | 695 | $25,981 | $22 |
| Hemoglobin a1c level | 718 | $20,067 | $13 |
| Dxa bone density measurement of hip, pelvis, spine | 329 | $20,024 | $60 |
| Thyroxine (thyroid chemical), free | 692 | $13,933 | $12 |
| Ultrasonic guidance for needle placement | 119 | $11,639 | $69 |
| New patient visit (60+ min) | 60 | $9,029 | $150 |
| Administration of influenza virus vaccine | 268 | $8,558 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $8,024 | $171 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 45 | $7,224 | $157 |
| Insertion of needle into vein for collection of blood sample | 1,085 | $6,442 | $3 |
| Spine scanning X-ray done with bone density measurement for spine compression | 252 | $6,167 | $24 |
| Injection of drug or substance under skin or into muscle | 67 | $4,798 | $23 |
| Thyroid hormone, t3 measurement, free | 120 | $4,553 | $23 |
| Blood glucose (sugar) level | 537 | $4,295 | $5 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 265 | $4,042 | $15 |
| New patient visit (30+ min) | 33 | $3,030 | $92 |
| Blood glucose (sugar) test performed by hand-held instrument | 536 | $2,606 | $3 |
| Long return visit (40+ min) | 24 | $2,431 | $101 |
| Urine microalbumin (protein) level | 272 | $2,396 | $8 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,245 | $61 |
| Creatinine level to test for kidney function or muscle injury | 268 | $2,118 | $7 |
| Short return visit | 50 | $2,088 | $39 |
| Cortisol (hormone) measurement, total | 31 | $1,766 | $22 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 42 | $1,622 | $37 |
| Thyroglobulin (thyroid protein) antibody measurement | 34 | $1,107 | $21 |
| Injection, cosyntropin, not otherwise specified, 0.25 mg | 21 | $1,004 | None |
| Blood glucose (sugar) measurement using reagent strip | 177 | $977 | $4 |
| Thyroglobulin (thyroid related hormone) level | 17 | $753 | $21 |
| Urinalysis, manual test | 114 | $472 | $3 |
2013: 34 services
| Return visit (30+ min) | 1,126 | $249,719 | $84 |
| Short return visit (20+ min) | 566 | $54,606 | $59 |
| Ultrasonic guidance for needle placement | 138 | $47,861 | $202 |
| Parathormone (parathyroid hormone) level | 366 | $37,100 | $56 |
| Ultrasound scan of head and neck soft tissue | 284 | $36,386 | $117 |
| Fine needle aspiration using imaging guidance | 140 | $32,505 | $130 |
| Blood test, thyroid stimulating hormone (tsh) | 735 | $29,302 | $23 |
| New patient visit (45+ min) | 202 | $27,169 | $135 |
| New patient visit (60+ min) | 151 | $24,945 | $165 |
| Hemoglobin a1c level | 721 | $21,148 | $13 |
| Dxa bone density measurement of hip, pelvis, spine | 333 | $20,280 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 107 | $19,586 | $165 |
| Thyroxine (thyroid chemical), free | 739 | $15,763 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $9,654 | $59 |
| Blood glucose (sugar) level | 733 | $8,995 | $5 |
| Insertion of needle into vein for collection of blood sample | 1,189 | $8,150 | $3 |
| Administration of influenza virus vaccine | 248 | $8,001 | $32 |
| Injection of drug or substance under skin or into muscle | 128 | $7,291 | $23 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 35 | $5,841 | $167 |
| Spine scanning X-ray done with bone density measurement for spine compression | 241 | $5,674 | $23 |
| Thyroid hormone, t3 measurement, free | 117 | $5,154 | $23 |
| Injection, denosumab, 1 mg | 11 | $5,140 | None |
| Long return visit (40+ min) | 36 | $4,255 | $109 |
| Urine microalbumin (protein) level | 334 | $3,194 | $8 |
| Creatinine level to test for kidney function or muscle injury | 334 | $2,851 | $7 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 208 | $2,455 | $12 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $2,309 | $32 |
| Blood glucose (sugar) measurement using reagent strip | 299 | $2,140 | $4 |
| Cortisol (hormone) measurement, total | 39 | $1,962 | $22 |
| Injection, cosyntropin, not otherwise specified, 0.25 mg | 23 | $1,490 | None |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 28 | $1,015 | $35 |
| Urinalysis, manual test | 171 | $773 | $3 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 41 | $603 | $14 |
| Thyroglobulin (thyroid protein) antibody measurement | 14 | $538 | $21 |
Medicaid work
$407,484 in 2024
Medicaid paid $407,484 for 11,285 billed services this clinician did in 2024, up to 284 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Injection, romosozumab-aqqg, 1 mg | 222 | $297,456 |
| Denosumab injection | 180 | $81,792 |
| Return visit (30+ min) | 2,419 | $10,317 |
| Short return visit (20+ min) | 1,690 | $5,236 |
| Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use | 64 | $1,863 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 740 | $1,681 |
| Fine needle aspiration biopsy, including ultrasound guidance; first lesion | 202 | $1,648 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 510 | $1,544 |
| New patient visit (45+ min) | 327 | $1,292 |
| Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment | 166 | $1,206 |
| Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 22 | $865 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 181 | $436 |
| 2024 | 11,285 | 36 | 284 | $407,484 |
| 2023 | 19,087 | 34 | 435 | $360,258 |
| 2022 | 14,489 | 27 | 349 | $199,946 |
| 2021 | 13,970 | 24 | 407 | $56,272 |
| 2020 | 10,205 | 21 | 311 | $29,148 |
| 2019 | 6,708 | 17 | 195 | $23,635 |
| 2018 | 4,786 | 14 | 151 | $21,490 |
See the largest Medicaid services in earlier years
2023
| Injection, romosozumab-aqqg, 1 mg | 251 | $223,556 |
| Denosumab injection | 229 | $89,683 |
| Return visit (30+ min) | 3,931 | $17,426 |
| Short return visit (20+ min) | 3,325 | $8,995 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 795 | $3,401 |
| New patient visit (45+ min) | 407 | $3,213 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 788 | $2,549 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 70 | $2,241 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 176 | $1,689 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 74 | $1,326 |
| New patient visit (30+ min) | 253 | $1,275 |
| Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment | 159 | $917 |
2022
| Injection, romosozumab-aqqg, 1 mg | 210 | $113,306 |
| Denosumab injection | 172 | $49,501 |
| Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use | 291 | $11,617 |
| Return visit (30+ min) | 2,572 | $7,557 |
| Short return visit (20+ min) | 3,439 | $6,439 |
| Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment | 279 | $2,409 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 698 | $2,377 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 679 | $2,293 |
| New patient visit (30+ min) | 282 | $1,167 |
| New patient visit (45+ min) | 247 | $1,074 |
| Fine needle aspiration biopsy, including ultrasound guidance; first lesion | 303 | $696 |
| Hemoglobin A1C level | 579 | $302 |
2021
| Denosumab injection | 128 | $23,506 |
| Return visit (30+ min) | 3,562 | $10,975 |
| Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use | 297 | $5,107 |
| Injection, romosozumab-aqqg, 1 mg | 14 | $5,009 |
| Short return visit (20+ min) | 2,537 | $4,060 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 595 | $1,627 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 542 | $1,534 |
| New patient visit (45+ min) | 366 | $1,146 |
| Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment | 229 | $943 |
| Fine needle aspiration biopsy, including ultrasound guidance; first lesion | 293 | $575 |
| New patient visit (30+ min) | 196 | $532 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 1,900 | $326 |
2020
| Return visit (30+ min) | 2,950 | $10,762 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 42 | $5,314 |
| Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use | 219 | $4,159 |
| Short return visit (20+ min) | 1,701 | $3,344 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 463 | $1,571 |
| New patient visit (45+ min) | 317 | $1,567 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 394 | $939 |
| Fine needle aspiration biopsy, including ultrasound guidance; first lesion | 205 | $470 |
| Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment | 152 | $317 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 1,512 | $306 |
| New patient visit (30+ min) | 27 | $126 |
| Hemoglobin A1C level | 452 | $98 |
2019
| Return visit (30+ min) | 1,951 | $8,994 |
| Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use | 135 | $4,922 |
| Short return visit (20+ min) | 1,551 | $3,589 |
| New patient visit (45+ min) | 260 | $1,703 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 390 | $1,397 |
| Long return visit (40+ min) | 166 | $900 |
| Fine needle aspiration biopsy, including ultrasound guidance; first lesion | 209 | $739 |
| New patient visit (30+ min) | 174 | $568 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 853 | $307 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 130 | $258 |
| Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment | 30 | $168 |
| New patient visit (60+ min) | 15 | $91 |
2018
| Return visit (30+ min) | 1,841 | $11,342 |
| Short return visit (20+ min) | 1,269 | $3,282 |
| New patient visit (45+ min) | 192 | $2,266 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 306 | $1,085 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 69 | $944 |
| Service | 166 | $837 |
| New patient visit (30+ min) | 96 | $754 |
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 148 | $386 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 385 | $311 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 85 | $273 |
| Hemoglobin A1C level | 32 | $9 |
| Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment | 25 | $0 |
Drugs they prescribed that Part D paid
$8,825,753
Pharmacies billed $8,825,753 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 14,843) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
6,986 generic and 7,097 brand-name prescriptions · $8,825,753 in drug cost · 19 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 1,000 | $1,616,758 | $1,617 |
| Jardiance | 885 | $1,108,758 | $1,253 |
| Trulicity | 654 | $948,751 | $1,451 |
| Mounjaro | 507 | $701,640 | $1,384 |
| Korlym | 12 | $465,403 | $38,784 |
See all 114 drugs
| Ozempic | 1,000 | $1,616,758 | $1,617 |
| Jardiance | 885 | $1,108,758 | $1,253 |
| Trulicity | 654 | $948,751 | $1,451 |
| Mounjaro | 507 | $701,640 | $1,384 |
| Korlym | 12 | $465,403 | $38,784 |
| Farxiga | 371 | $413,617 | $1,115 |
| Afrezza | 109 | $392,762 | $3,603 |
| Rybelsus | 209 | $372,971 | $1,785 |
| Kerendia | 259 | $303,545 | $1,172 |
| Humalog Kwikpen U-200 | 64 | $155,424 | $2,429 |
| Repatha Sureclick | 161 | $147,085 | $914 |
| Tymlos | 47 | $129,318 | $2,751 |
| Synjardy Xr | 101 | $112,616 | $1,115 |
| Tradjenta | 116 | $110,913 | $956 |
| Invokana | 79 | $107,691 | $1,363 |
| Forteo | 21 | $101,164 | $4,817 |
| Tresiba Flextouch U-100 | 156 | $91,551 | $587 |
| Januvia | 77 | $85,260 | $1,107 |
| Xigduo Xr | 80 | $72,756 | $909 |
| Toujeo Solostar | 122 | $70,224 | $576 |
| Prolia | 39 | $67,213 | $1,723 |
| Fiasp Flextouch | 65 | $64,859 | $998 |
| Evenity (2 Syringes) | 28 | $64,574 | $2,306 |
| Synjardy | 49 | $61,045 | $1,246 |
| Humalog Kwikpen U-100 | 165 | $60,361 | $366 |
| Lyumjev Kwikpen U-100 | 48 | $59,716 | $1,244 |
| Teriparatide | 28 | $55,888 | $1,996 |
| Nano 2nd Gen Pen Needle | 372 | $54,165 | $146 |
| Toujeo Max Solostar | 42 | $46,445 | $1,106 |
| Vascepa | 53 | $38,900 | $734 |
| Cinacalcet | 38 | $37,178 | $978 |
| Lyumjev Kwikpen U-200 | 16 | $36,621 | $2,289 |
| Bydureon Bcise | 14 | $33,624 | $2,402 |
| Synthroid | 312 | $33,265 | $107 |
| Gvoke Hypopen 2-Pack | 42 | $26,259 | $625 |
| Praluent | 29 | $24,644 | $850 |
| Repaglinide | 486 | $23,589 | $49 |
| Tresiba Flextouch U-200 | 21 | $22,088 | $1,052 |
| Basaglar Kwikpen U-100 | 65 | $21,450 | $330 |
| Levothyroxine | 1,218 | $19,727 | $16 |
| Lantus Solostar | 134 | $19,334 | $144 |
| Insulin Lispro Kwikpen U-100 | 56 | $18,586 | $332 |
| Tirosint | 64 | $18,238 | $285 |
| Novolog Flexpen | 74 | $16,867 | $228 |
| Dapagliflozin | 26 | $13,652 | $525 |
| Icosapent Ethyl | 29 | $10,785 | $372 |
| Ultra-Fine Nano Pen Needle | 94 | $10,312 | $110 |
| Admelog Solostar | 22 | $9,469 | $430 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | 14 | $9,455 | $675 |
| Testosterone | 62 | $8,397 | $135 |
| Baqsimi | 15 | $8,193 | $546 |
| Metformin | 719 | $6,728 | $9 |
| Comfort Ez Pen Needle | 37 | $5,944 | $161 |
| Insulin Aspart Flexpen | 26 | $5,866 | $226 |
| Atorvastatin | 478 | $5,474 | $11 |
| Ezetimibe | 161 | $5,312 | $33 |
| Metformin Hcl Er | 379 | $5,266 | $14 |
| Nateglinide | 55 | $4,375 | $80 |
| Losartan | 441 | $4,248 | $10 |
| Pioglitazone | 304 | $4,042 | $13 |
| Rosuvastatin | 200 | $3,993 | $20 |
| Tirosint-Sol | 14 | $3,924 | $280 |
| Hydrocortisone | 71 | $3,349 | $47 |
| Amlodipine Besylate | 413 | $3,147 | $8 |
| Humalog | 12 | $3,138 | $262 |
| Droplet Pen Needle | 24 | $3,045 | $127 |
| Olmesartan Medoxomil | 94 | $3,010 | $32 |
| Ulticare Pen Needle | 39 | $2,777 | $71 |
| Ultra-Fine Short Pen Needle | 28 | $2,755 | $98 |
| Alendronate | 251 | $2,487 | $10 |
| Valsartan | 82 | $2,461 | $30 |
| Ultra-Fine Mini Pen Needle | 21 | $2,125 | $101 |
| Losartan-Hydrochlorothiazide | 88 | $2,059 | $23 |
| Gabapentin | 74 | $1,522 | $21 |
| Methimazole | 158 | $1,509 | $10 |
| Paxlovid | 32 | $1,411 | $44 |
| Alcohol Pads | 34 | $1,235 | $36 |
| Simvastatin | 161 | $1,203 | $7 |
| Testosterone Cypionate | 74 | $1,167 | $16 |
| Metoprolol | 66 | $1,144 | $17 |
| Pregabalin | 24 | $1,014 | $42 |
| Alcohol Prep Pads | 23 | $920 | $40 |
| Hydrochlorothiazide | 173 | $911 | $5 |
| Irbesartan | 50 | $842 | $17 |
| Atenolol | 100 | $822 | $8 |
| Lisinopril | 105 | $820 | $8 |
| Valsartan-Hydrochlorothiazide | 21 | $786 | $37 |
| Calcitriol | 42 | $760 | $18 |
| Fenofibrate | 21 | $747 | $36 |
| Fenofibrate | 17 | $577 | $34 |
| Cabergoline | 17 | $562 | $33 |
| Vitamin D2 | 35 | $521 | $15 |
| Omeprazole | 25 | $504 | $20 |
| Fluconazole | 23 | $495 | $22 |
| Liothyronine | 13 | $470 | $36 |
| Fenofibrate | 18 | $449 | $25 |
| Enalapril Maleate | 12 | $378 | $32 |
| Ondansetron | 27 | $362 | $13 |
| Pravastatin | 43 | $333 | $8 |
| Spironolactone | 19 | $314 | $17 |
| Benazepril | 24 | $307 | $13 |
| Pantoprazole | 28 | $304 | $11 |
| Olmesartan-Hydrochlorothiazide | 20 | $294 | $15 |
| Metoprolol | 22 | $284 | $13 |
| Fludrocortisone Acetate | 11 | $260 | $24 |
| Carvedilol | 18 | $248 | $14 |
| Finasteride | 12 | $241 | $20 |
| Glipizide | 22 | $218 | $10 |
| Naproxen | 13 | $186 | $14 |
| Metoclopramide | 11 | $141 | $13 |
| Tamsulosin | 15 | $130 | $9 |
| Ramipril | 15 | $97 | $6 |
| Triamcinolone Acetonide | 11 | $38 | $3 |
| Dexamethasone | 35 | $32 | $1 |
Year by year
| 2024 | 14,843 | 1,521 | 0% (0) | 48% | $8,825,753 |
| 2023 | 14,249 | 1,452 | 0% (0) | 49% | $9,692,265 |
| 2022 | 13,619 | 1,416 | 0% (0) | 48% | $8,274,638 |
| 2021 | 12,960 | 1,322 | 0% (0) | 48% | $7,026,409 |
| 2020 | 15,027 | 1,373 | None | 50% | $7,548,852 |
| 2019 | 14,927 | 1,375 | 0% (0) | 48% | $6,864,466 |
| 2018 | 14,773 | 1,198 | 0% (0) | 46% | $5,242,526 |
| 2017 | 14,096 | 1,016 | None | 44% | $3,696,107 |
| 2016 | 13,835 | 1,008 | 0% (0) | 43% | $3,202,491 |
| 2015 | 12,336 | 904 | None | 45% | $2,654,318 |
| 2014 | 11,946 | 896 | None | 47% | $2,275,029 |
| 2013 | 11,686 | 867 | None | 50% | $1,939,282 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 119 drugs
| Trulicity | 907 | $1,557,583 | $1,717 |
| Ozempic | 715 | $1,228,229 | $1,718 |
| Jardiance | 790 | $1,024,435 | $1,297 |
| Farxiga | 509 | $619,420 | $1,217 |
| Korlym | 12 | $432,572 | $36,048 |
| Rybelsus | 241 | $407,815 | $1,692 |
| Kerendia | 237 | $318,159 | $1,342 |
| Afrezza | 92 | $305,073 | $3,316 |
| Forteo | 57 | $284,405 | $4,990 |
| Novolog Flexpen | 217 | $270,305 | $1,246 |
| Mounjaro | 145 | $225,720 | $1,557 |
| Humalog Kwikpen U-100 | 164 | $217,439 | $1,326 |
| Invokana | 108 | $167,619 | $1,552 |
| Humalog Kwikpen U-200 | 45 | $156,250 | $3,472 |
| Tymlos | 42 | $138,099 | $3,288 |
| Tradjenta | 115 | $127,274 | $1,107 |
| Repatha Sureclick | 113 | $118,313 | $1,047 |
| Synjardy Xr | 79 | $101,417 | $1,284 |
| Victoza 3-Pak | 47 | $98,811 | $2,102 |
| Tresiba Flextouch U-100 | 153 | $95,449 | $624 |
| Evenity (2 Syringes) | 39 | $94,548 | $2,424 |
| Lantus Solostar | 129 | $85,693 | $664 |
| Januvia | 74 | $84,065 | $1,136 |
| Prolia | 45 | $74,229 | $1,650 |
| Toujeo Solostar | 134 | $70,580 | $527 |
| Fiasp Flextouch | 55 | $67,689 | $1,231 |
| Cinacalcet | 45 | $59,207 | $1,316 |
| Xigduo Xr | 54 | $59,035 | $1,093 |
| Lyumjev Kwikpen U-100 | 49 | $56,088 | $1,145 |
| Toujeo Max Solostar | 46 | $54,171 | $1,178 |
| Vascepa | 67 | $53,387 | $797 |
| Bydureon Bcise | 28 | $52,336 | $1,869 |
| Praluent | 48 | $48,831 | $1,017 |
| Nano 2nd Gen Pen Needle | 282 | $43,094 | $153 |
| Synjardy | 27 | $41,453 | $1,535 |
| Tresiba Flextouch U-200 | 28 | $41,407 | $1,479 |
| Basaglar Kwikpen U-100 | 100 | $40,621 | $406 |
| Repaglinide | 406 | $39,651 | $98 |
| Synthroid | 329 | $39,345 | $120 |
| Gvoke Hypopen 2-Pack | 53 | $36,107 | $681 |
| Levothyroxine | 1,097 | $24,386 | $22 |
| Icosapent Ethyl | 36 | $21,552 | $599 |
| Victoza 2-Pak | 14 | $20,111 | $1,436 |
| Tirosint | 54 | $17,468 | $323 |
| Insulin Lispro Kwikpen U-100 | 34 | $15,691 | $461 |
| Xultophy 100-3.6 | 11 | $15,186 | $1,381 |
| Testosterone | 73 | $15,140 | $207 |
| Soliqua 100-33 | 12 | $15,044 | $1,254 |
| Repatha Pushtronex | 17 | $14,123 | $831 |
| Ultra-Fine Nano Pen Needle | 91 | $13,508 | $148 |
| Humalog | 14 | $13,506 | $965 |
| Metformin | 709 | $13,201 | $19 |
| Ezetimibe | 160 | $9,814 | $61 |
| Pioglitazone | 282 | $9,723 | $34 |
| Metformin Hcl Er | 356 | $9,492 | $27 |
| Xyosted | 12 | $9,076 | $756 |
| Atorvastatin | 479 | $8,920 | $19 |
| Baqsimi | 15 | $8,883 | $592 |
| Ulticare Pen Needle | 72 | $8,530 | $118 |
| Rosuvastatin | 189 | $7,792 | $41 |
| Nateglinide | 58 | $7,785 | $134 |
| Losartan | 420 | $7,647 | $18 |
| Omnipod 5 G6 Pods (Gen 5) | 12 | $7,466 | $622 |
| Nexletol | 13 | $7,405 | $570 |
| Invokamet | 12 | $7,171 | $598 |
| Edarbi | 11 | $6,588 | $599 |
| Comfort Ez Pen Needle | 28 | $6,232 | $223 |
| Amlodipine Besylate | 358 | $5,039 | $14 |
| Hydrocortisone | 62 | $4,859 | $78 |
| Alendronate | 260 | $4,387 | $17 |
| Insulin Aspart Flexpen | 15 | $4,177 | $278 |
| Olmesartan Medoxomil | 94 | $3,605 | $38 |
| Valsartan | 60 | $3,471 | $58 |
| Methimazole | 165 | $2,911 | $18 |
| Gabapentin | 83 | $2,587 | $31 |
| Ultra-Fine Short Pen Needle | 24 | $2,479 | $103 |
| Losartan-Hydrochlorothiazide | 57 | $2,447 | $43 |
| Droplet Pen Needle | 16 | $2,388 | $149 |
| Irbesartan | 52 | $2,369 | $46 |
| Simvastatin | 149 | $2,293 | $15 |
| Pregabalin | 27 | $1,960 | $73 |
| Valsartan-Hydrochlorothiazide | 30 | $1,855 | $62 |
| Hydrochlorothiazide | 190 | $1,724 | $9 |
| Lisinopril | 120 | $1,622 | $14 |
| Cabergoline | 16 | $1,589 | $99 |
| Acarbose | 19 | $1,529 | $80 |
| Atenolol | 79 | $1,395 | $18 |
| Pentips | 34 | $1,384 | $41 |
| Easy Touch Pen Needle | 12 | $1,340 | $112 |
| Fenofibrate | 29 | $1,315 | $45 |
| Metoprolol | 54 | $1,296 | $24 |
| Sure Comfort Pen Needle | 13 | $1,233 | $95 |
| Calcitriol | 24 | $1,194 | $50 |
| Alcohol Pads | 23 | $1,059 | $46 |
| Testosterone Cypionate | 53 | $1,004 | $19 |
| Pravastatin | 51 | $830 | $16 |
| Fluconazole | 23 | $718 | $31 |
| Benazepril | 29 | $711 | $25 |
| Ultracare Pen Needle | 15 | $705 | $47 |
| Ondansetron | 25 | $608 | $24 |
| Enalapril Maleate | 21 | $567 | $27 |
| Omeprazole | 27 | $535 | $20 |
| Glipizide | 33 | $503 | $15 |
| Fenofibrate | 12 | $421 | $35 |
| Paxlovid (Eua) | 43 | $398 | $9 |
| Tamsulosin | 21 | $387 | $18 |
| Ramipril | 17 | $386 | $23 |
| Metoprolol | 31 | $377 | $12 |
| Spironolactone | 20 | $377 | $19 |
| Vitamin D2 | 42 | $353 | $8 |
| Alcohol Prep Pads | 13 | $351 | $27 |
| Pantoprazole | 16 | $339 | $21 |
| Carvedilol | 22 | $317 | $14 |
| Diclofenac | 11 | $265 | $24 |
| Glimepiride | 13 | $241 | $19 |
| Lovastatin | 11 | $237 | $22 |
| Triamcinolone Acetonide | 14 | $152 | $11 |
| Lisinopril-Hydrochlorothiazide | 11 | $135 | $12 |
| Dexamethasone | 30 | $35 | $1 |
2022: 118 drugs
| Trulicity | 948 | $1,551,880 | $1,637 |
| Ozempic | 527 | $955,091 | $1,812 |
| Jardiance | 690 | $810,170 | $1,174 |
| Farxiga | 488 | $563,138 | $1,154 |
| Korlym | 13 | $451,232 | $34,710 |
| Novolog Flexpen | 277 | $326,977 | $1,180 |
| Rybelsus | 240 | $325,403 | $1,356 |
| Invokana | 155 | $217,848 | $1,405 |
| Kerendia | 195 | $200,314 | $1,027 |
| Humalog Kwikpen U-100 | 139 | $144,277 | $1,038 |
| Evenity (2 Syringes) | 62 | $141,300 | $2,279 |
| Forteo | 33 | $140,581 | $4,260 |
| Tymlos | 57 | $131,356 | $2,304 |
| Victoza 3-Pak | 61 | $122,721 | $2,012 |
| Afrezza | 45 | $111,516 | $2,478 |
| Tradjenta | 118 | $111,126 | $942 |
| Humalog Kwikpen U-200 | 39 | $109,538 | $2,809 |
| Synjardy Xr | 95 | $99,504 | $1,047 |
| Repatha Sureclick | 111 | $96,155 | $866 |
| Bydureon Bcise | 68 | $86,942 | $1,279 |
| Januvia | 78 | $78,238 | $1,003 |
| Toujeo Solostar | 141 | $76,961 | $546 |
| Prolia | 50 | $72,900 | $1,458 |
| Xigduo Xr | 68 | $69,097 | $1,016 |
| Lantus Solostar | 118 | $62,364 | $529 |
| Vascepa | 80 | $58,869 | $736 |
| Fiasp Flextouch | 44 | $51,846 | $1,178 |
| Tresiba Flextouch U-100 | 84 | $49,002 | $583 |
| Cinacalcet | 51 | $48,747 | $956 |
| Basaglar Kwikpen U-100 | 114 | $47,262 | $415 |
| Toujeo Max Solostar | 47 | $47,138 | $1,003 |
| Repaglinide | 392 | $38,626 | $99 |
| Synthroid | 339 | $37,049 | $109 |
| Praluent | 34 | $33,837 | $995 |
| Nano 2nd Gen Pen Needle | 271 | $33,581 | $124 |
| Synjardy | 24 | $32,882 | $1,370 |
| Gvoke Hypopen 2-Pack | 34 | $29,227 | $860 |
| Tresiba Flextouch U-200 | 22 | $28,541 | $1,297 |
| Lyumjev Kwikpen U-100 | 24 | $24,229 | $1,010 |
| Mounjaro | 12 | $22,836 | $1,903 |
| Levothyroxine | 1,043 | $22,794 | $22 |
| Soliqua 100-33 | 17 | $18,944 | $1,114 |
| Icosapent Ethyl | 37 | $18,777 | $507 |
| Humalog | 20 | $17,879 | $894 |
| Invokamet | 18 | $17,628 | $979 |
| Repatha Pushtronex | 17 | $16,041 | $944 |
| Testosterone | 80 | $15,624 | $195 |
| Comfort Ez Pen Needle | 76 | $14,142 | $186 |
| Insulin Lispro Kwikpen U-100 | 39 | $12,947 | $332 |
| Tirosint | 36 | $12,399 | $344 |
| Nateglinide | 67 | $11,997 | $179 |
| Baqsimi | 16 | $10,715 | $670 |
| Ultra-Fine Nano Pen Needle | 75 | $10,141 | $135 |
| Ezetimibe | 133 | $8,679 | $65 |
| Nexletol | 19 | $8,675 | $457 |
| Rosuvastatin | 170 | $7,960 | $47 |
| Metformin | 696 | $7,397 | $11 |
| Atorvastatin | 428 | $6,587 | $15 |
| Metformin Hcl Er | 319 | $6,568 | $21 |
| Natesto | 12 | $6,449 | $537 |
| Pioglitazone | 289 | $6,134 | $21 |
| Losartan | 383 | $5,431 | $14 |
| Ulticare Pen Needle | 31 | $4,720 | $152 |
| Hydrocortisone | 52 | $4,458 | $86 |
| Lantus | 14 | $4,009 | $286 |
| Alendronate | 258 | $3,828 | $15 |
| Amlodipine Besylate | 347 | $3,683 | $11 |
| Edarbyclor | 12 | $3,652 | $304 |
| Cabergoline | 20 | $3,432 | $172 |
| Fenofibrate | 50 | $3,255 | $65 |
| Ultra-Fine Short Pen Needle | 32 | $3,066 | $96 |
| Easy Comfort Pen Needles | 26 | $2,857 | $110 |
| Valsartan | 48 | $2,735 | $57 |
| Losartan-Hydrochlorothiazide | 56 | $2,684 | $48 |
| Methimazole | 148 | $2,625 | $18 |
| Olmesartan Medoxomil | 78 | $2,528 | $32 |
| Acarbose | 13 | $2,147 | $165 |
| Testosterone Cypionate | 92 | $2,143 | $23 |
| Simvastatin | 158 | $1,870 | $12 |
| Gabapentin | 82 | $1,834 | $22 |
| Easy Comfort Pen Needle | 12 | $1,778 | $148 |
| Irbesartan | 41 | $1,725 | $42 |
| Hydrochlorothiazide | 202 | $1,497 | $7 |
| Pregabalin | 29 | $1,414 | $49 |
| Droplet Pen Needle | 13 | $1,380 | $106 |
| Fenofibrate | 16 | $1,356 | $85 |
| Omega-3 Acid Ethyl Esters | 14 | $1,277 | $91 |
| Lisinopril | 126 | $1,127 | $9 |
| Valsartan-Hydrochlorothiazide | 13 | $1,105 | $85 |
| Atenolol | 94 | $1,044 | $11 |
| Olmesartan-Hydrochlorothiazide | 14 | $970 | $69 |
| Alcohol Pads | 23 | $903 | $39 |
| Enalapril Maleate | 30 | $886 | $30 |
| Omeprazole | 36 | $840 | $23 |
| Metoprolol | 53 | $814 | $15 |
| Fluconazole | 26 | $791 | $30 |
| Pravastatin | 46 | $790 | $17 |
| Benazepril | 31 | $729 | $24 |
| Easy Touch Pen Needle | 15 | $692 | $46 |
| Alcohol Prep Pads | 25 | $679 | $27 |
| Glipizide Er | 18 | $664 | $37 |
| Ultracare Pen Needle | 13 | $663 | $51 |
| Ondansetron | 27 | $656 | $24 |
| Calcitriol | 23 | $622 | $27 |
| Carvedilol | 28 | $387 | $14 |
| Glipizide | 36 | $315 | $9 |
| Ramipril | 22 | $298 | $14 |
| Vitamin D2 | 37 | $287 | $8 |
| Spironolactone | 14 | $261 | $19 |
| Fosinopril | 13 | $258 | $20 |
| Insulin | 14 | $257 | $18 |
| Euthyrox | 16 | $235 | $15 |
| Paxlovid (Eua) | 31 | $235 | $8 |
| Metoprolol | 34 | $224 | $7 |
| Tamsulosin | 13 | $224 | $17 |
| Glimepiride | 13 | $202 | $16 |
| Triamcinolone Acetonide | 18 | $91 | $5 |
| Dexamethasone | 31 | $39 | $1 |
2021: 120 drugs
| Trulicity | 909 | $1,387,989 | $1,527 |
| Ozempic | 494 | $806,169 | $1,632 |
| Jardiance | 550 | $637,466 | $1,159 |
| Farxiga | 353 | $376,745 | $1,067 |
| Novolog Flexpen | 267 | $312,803 | $1,172 |
| Invokana | 242 | $291,831 | $1,206 |
| Rybelsus | 145 | $213,847 | $1,475 |
| Victoza 3-Pak | 96 | $186,144 | $1,939 |
| Bydureon Bcise | 123 | $153,898 | $1,251 |
| Afrezza | 55 | $134,177 | $2,440 |
| Forteo | 34 | $133,843 | $3,937 |
| Humalog Kwikpen U-100 | 136 | $129,612 | $953 |
| Lantus Solostar | 213 | $121,191 | $569 |
| Humalog Kwikpen U-200 | 36 | $99,161 | $2,754 |
| Januvia | 111 | $98,927 | $891 |
| Toujeo Solostar | 157 | $96,227 | $613 |
| Tradjenta | 98 | $89,843 | $917 |
| Repatha Sureclick | 98 | $79,612 | $812 |
| Prolia | 58 | $79,483 | $1,370 |
| Xigduo Xr | 66 | $71,031 | $1,076 |
| Synjardy Xr | 67 | $71,008 | $1,060 |
| Tymlos | 30 | $64,201 | $2,140 |
| Vascepa | 95 | $60,942 | $641 |
| Toujeo Max Solostar | 45 | $49,008 | $1,089 |
| Fiasp Flextouch | 46 | $44,728 | $972 |
| Synjardy | 33 | $44,558 | $1,350 |
| Insulin Lispro Kwikpen U-100 | 59 | $42,037 | $712 |
| Basaglar Kwikpen U-100 | 95 | $41,952 | $442 |
| Evenity (2 Syringes) | 20 | $41,425 | $2,071 |
| Tresiba Flextouch U-100 | 77 | $40,281 | $523 |
| Cinacalcet | 38 | $39,473 | $1,039 |
| Kerendia | 42 | $36,716 | $874 |
| Repaglinide | 379 | $34,066 | $90 |
| Lyumjev Kwikpen U-100 | 28 | $33,366 | $1,192 |
| Praluent | 53 | $32,321 | $610 |
| Synthroid | 299 | $32,246 | $108 |
| Humalog | 35 | $29,294 | $837 |
| Nano 2nd Gen Pen Needle | 297 | $28,796 | $97 |
| Tresiba Flextouch U-200 | 22 | $26,951 | $1,225 |
| Invokamet | 37 | $26,907 | $727 |
| Levothyroxine | 982 | $22,508 | $23 |
| Victoza 2-Pak | 15 | $22,478 | $1,499 |
| Janumet | 13 | $17,720 | $1,363 |
| Soliqua 100-33 | 17 | $15,507 | $912 |
| Repatha | 15 | $15,213 | $1,014 |
| Ultra-Fine Nano Pen Needle | 107 | $12,481 | $117 |
| Repatha Pushtronex | 18 | $11,925 | $662 |
| Testosterone | 66 | $11,491 | $174 |
| Jentadueto | 11 | $10,813 | $983 |
| Icosapent Ethyl | 27 | $10,669 | $395 |
| Nateglinide | 67 | $10,593 | $158 |
| Rosuvastatin | 166 | $10,503 | $63 |
| Comfort Ez Pen Needle | 66 | $9,282 | $141 |
| Nexletol | 18 | $7,998 | $444 |
| Linzess | 15 | $7,403 | $494 |
| Metformin | 664 | $6,668 | $10 |
| Baqsimi | 12 | $6,416 | $535 |
| Ezetimibe | 90 | $6,357 | $71 |
| Easy Comfort Pen Needles | 47 | $6,244 | $133 |
| Levemir Flextouch | 14 | $5,908 | $422 |
| Metformin Hcl Er | 347 | $5,752 | $17 |
| Hydrocortisone | 70 | $5,713 | $82 |
| Pioglitazone | 301 | $5,671 | $19 |
| Atorvastatin | 369 | $5,407 | $15 |
| Gvoke Hypopen 2-Pack | 12 | $5,329 | $444 |
| Natesto | 13 | $5,141 | $395 |
| Ulticare Pen Needle | 56 | $4,809 | $86 |
| Tirosint | 15 | $4,313 | $288 |
| Losartan | 307 | $4,109 | $13 |
| Olmesartan Medoxomil | 86 | $4,051 | $47 |
| Amlodipine Besylate | 326 | $3,252 | $10 |
| Valsartan | 45 | $3,224 | $72 |
| Omega-3 Acid Ethyl Esters | 22 | $3,200 | $145 |
| Alendronate | 276 | $2,898 | $10 |
| Alcohol Pads | 63 | $2,711 | $43 |
| Ultra-Fine Short Pen Needle | 34 | $2,649 | $78 |
| Cabergoline | 14 | $2,446 | $175 |
| Telmisartan-Hydrochlorothiazid | 13 | $2,316 | $178 |
| Easy Comfort Pen Needle | 14 | $2,248 | $161 |
| Fenofibrate | 28 | $2,142 | $76 |
| Acarbose | 14 | $2,001 | $143 |
| Testosterone Cypionate | 69 | $1,952 | $28 |
| Ultracare Pen Needle | 26 | $1,849 | $71 |
| Methimazole | 113 | $1,840 | $16 |
| Gabapentin | 92 | $1,837 | $20 |
| Valsartan-Hydrochlorothiazide | 12 | $1,715 | $143 |
| Irbesartan | 44 | $1,589 | $36 |
| Fenofibrate | 19 | $1,541 | $81 |
| Simvastatin | 169 | $1,520 | $9 |
| Pregabalin | 25 | $1,430 | $57 |
| Desmopressin Acetate | 11 | $1,379 | $125 |
| Hydrochlorothiazide | 159 | $1,346 | $8 |
| Droplet Pen Needle | 11 | $1,240 | $113 |
| Lisinopril | 137 | $1,151 | $8 |
| Ultra-Fine Mini Pen Needle | 14 | $1,064 | $76 |
| Losartan-Hydrochlorothiazide | 37 | $1,051 | $28 |
| Calcitriol | 32 | $952 | $30 |
| Metoprolol | 40 | $872 | $22 |
| Atenolol | 84 | $780 | $9 |
| Alcohol Prep Pads | 29 | $721 | $25 |
| Omeprazole | 34 | $644 | $19 |
| Pravastatin | 34 | $595 | $17 |
| Carvedilol | 37 | $480 | $13 |
| Ondansetron | 24 | $433 | $18 |
| Fluconazole | 46 | $378 | $8 |
| Vitamin D2 | 48 | $350 | $7 |
| Enalapril Maleate | 11 | $322 | $29 |
| Glipizide Er | 11 | $253 | $23 |
| Benazepril | 15 | $245 | $16 |
| Metoprolol | 27 | $198 | $7 |
| Euthyrox | 16 | $183 | $11 |
| Clopidogrel | 12 | $152 | $13 |
| Triamcinolone Acetonide | 22 | $123 | $6 |
| Glipizide | 19 | $115 | $6 |
| Ramipril | 12 | $113 | $9 |
| Glimepiride | 13 | $109 | $8 |
| Allopurinol | 13 | $89 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $84 | $8 |
| Furosemide | 13 | $69 | $5 |
| Dexamethasone | 19 | $16 | $1 |
2020: 127 drugs
| Trulicity | 1,037 | $1,386,174 | $1,337 |
| Ozempic | 427 | $609,902 | $1,428 |
| Jardiance | 573 | $576,064 | $1,005 |
| Novolog Flexpen | 489 | $570,946 | $1,168 |
| Victoza 3-Pak | 246 | $422,381 | $1,717 |
| Invokana | 402 | $375,829 | $935 |
| Farxiga | 255 | $261,906 | $1,027 |
| Humalog Kwikpen U-100 | 263 | $253,449 | $964 |
| Forteo | 60 | $226,648 | $3,777 |
| Bydureon Bcise | 196 | $216,763 | $1,106 |
| Tradjenta | 184 | $174,825 | $950 |
| Lantus Solostar | 331 | $165,216 | $499 |
| Toujeo Solostar | 225 | $142,771 | $635 |
| Januvia | 159 | $137,812 | $867 |
| Tymlos | 55 | $127,251 | $2,314 |
| Prolia | 97 | $124,776 | $1,286 |
| Afrezza | 49 | $82,470 | $1,683 |
| Humalog Kwikpen U-200 | 41 | $68,826 | $1,679 |
| Repatha Sureclick | 92 | $66,156 | $719 |
| Rybelsus | 53 | $61,497 | $1,160 |
| Vascepa | 115 | $60,771 | $528 |
| Cinacalcet | 69 | $60,260 | $873 |
| Tresiba Flextouch U-100 | 108 | $59,911 | $555 |
| Tresiba Flextouch U-200 | 59 | $59,557 | $1,009 |
| Basaglar Kwikpen U-100 | 181 | $58,575 | $324 |
| Xigduo Xr | 53 | $55,872 | $1,054 |
| Synjardy Xr | 41 | $47,400 | $1,156 |
| Praluent | 61 | $41,940 | $688 |
| Bydureon | 35 | $41,038 | $1,173 |
| Ultra-Fine Nano Pen Needle | 408 | $40,872 | $100 |
| Humalog | 44 | $38,062 | $865 |
| Repaglinide | 377 | $37,874 | $100 |
| Invokamet | 62 | $37,203 | $600 |
| Insulin Lispro Kwikpen U-100 | 50 | $34,041 | $681 |
| Victoza 2-Pak | 15 | $31,649 | $2,110 |
| Fiasp Flextouch | 36 | $28,743 | $798 |
| Synthroid | 274 | $27,119 | $99 |
| Synjardy | 19 | $26,782 | $1,410 |
| Levothyroxine | 970 | $24,837 | $26 |
| Toujeo Max Solostar | 30 | $24,414 | $814 |
| Janumet | 30 | $23,670 | $789 |
| Apidra Solostar | 14 | $22,121 | $1,580 |
| Lantus | 34 | $20,848 | $613 |
| Repatha | 25 | $19,804 | $792 |
| Testosterone | 66 | $18,236 | $276 |
| Ultracare Pen Needle | 152 | $15,231 | $100 |
| Levemir Flextouch | 25 | $14,544 | $582 |
| Janumet Xr | 17 | $13,706 | $806 |
| Nateglinide | 101 | $13,422 | $133 |
| Nano 2nd Gen Pen Needle | 105 | $11,893 | $113 |
| Easy Comfort Pen Needles | 80 | $11,040 | $138 |
| Admelog Solostar | 30 | $9,773 | $326 |
| Ezetimibe | 109 | $9,102 | $84 |
| Rosuvastatin | 148 | $8,220 | $56 |
| Comfort Ez Pen Needle | 50 | $7,759 | $155 |
| Ulticare Pen Needle | 94 | $7,740 | $82 |
| Repatha Pushtronex | 15 | $7,667 | $511 |
| Soliqua 100-33 | 11 | $7,387 | $672 |
| Gvoke Pfs 1-Pack | 13 | $7,272 | $559 |
| Pioglitazone | 329 | $6,950 | $21 |
| Metformin | 805 | $6,723 | $8 |
| Atorvastatin | 446 | $6,507 | $15 |
| Tirosint | 25 | $6,418 | $257 |
| Metformin Hcl Er | 339 | $6,104 | $18 |
| Ultra-Fine Short Pen Needle | 71 | $5,540 | $78 |
| Valsartan | 42 | $4,170 | $99 |
| Losartan | 288 | $4,006 | $14 |
| Alcohol Pads | 79 | $3,828 | $48 |
| Losartan-Hydrochlorothiazide | 33 | $3,772 | $114 |
| Glucagon Emergency Kit | 12 | $3,744 | $312 |
| Hydrocortisone | 82 | $3,744 | $46 |
| Olmesartan Medoxomil | 81 | $3,482 | $43 |
| Easy Comfort Pen Needle | 25 | $3,109 | $124 |
| Ultra-Fine Mini Pen Needle | 48 | $3,108 | $65 |
| Amlodipine Besylate | 338 | $2,761 | $8 |
| Omega-3 Acid Ethyl Esters | 13 | $2,678 | $206 |
| Irbesartan | 53 | $2,449 | $46 |
| Methimazole | 168 | $2,319 | $14 |
| Fenofibrate | 34 | $2,268 | $67 |
| Alendronate | 256 | $2,114 | $8 |
| Fenofibrate | 22 | $2,072 | $94 |
| Alcohol Prep Pads | 28 | $2,014 | $72 |
| Testosterone Cypionate | 56 | $1,910 | $34 |
| Telmisartan-Hydrochlorothiazid | 12 | $1,899 | $158 |
| Gabapentin | 118 | $1,638 | $14 |
| Novofine 32 | 13 | $1,458 | $112 |
| Simvastatin | 158 | $1,456 | $9 |
| Droplet Pen Needle | 13 | $1,402 | $108 |
| Metoprolol | 76 | $1,371 | $18 |
| Risedronate | 17 | $1,249 | $73 |
| Hydrochlorothiazide | 166 | $1,172 | $7 |
| Lisinopril | 133 | $1,091 | $8 |
| Calcitriol | 36 | $1,071 | $30 |
| Valsartan-Hydrochlorothiazide | 14 | $940 | $67 |
| Pravastatin | 62 | $939 | $15 |
| Liothyronine | 12 | $801 | $67 |
| Insulin | 13 | $759 | $58 |
| Ultra-Fine Original Pen Needle | 14 | $692 | $49 |
| Atenolol | 72 | $680 | $9 |
| Pregabalin | 13 | $612 | $47 |
| Enalapril Maleate | 13 | $605 | $47 |
| Telmisartan | 16 | $583 | $36 |
| Glimepiride | 35 | $550 | $16 |
| Easy Touch Pen Needle | 16 | $477 | $30 |
| Unifine Pentips | 20 | $456 | $23 |
| Irbesartan-Hydrochlorothiazide | 12 | $456 | $38 |
| Potassium Chloride | 12 | $451 | $38 |
| Carvedilol | 43 | $409 | $10 |
| Omeprazole | 29 | $405 | $14 |
| Glipizide | 47 | $396 | $8 |
| Pentips | 12 | $394 | $33 |
| Metoprolol | 53 | $286 | $5 |
| Fosinopril | 15 | $260 | $17 |
| Benazepril | 21 | $257 | $12 |
| Clopidogrel | 24 | $248 | $10 |
| Estradiol | 11 | $222 | $20 |
| Vitamin D2 | 22 | $192 | $9 |
| Fluconazole | 39 | $179 | $5 |
| Prednisone | 11 | $170 | $15 |
| Tamsulosin | 12 | $151 | $13 |
| Pantoprazole | 17 | $118 | $7 |
| Furosemide | 18 | $112 | $6 |
| Lovastatin | 17 | $100 | $6 |
| Ramipril | 17 | $88 | $5 |
| Allopurinol | 11 | $60 | $5 |
| Single Use Swab | 13 | $35 | $3 |
| Dexamethasone | 14 | $19 | $1 |
2019: 116 drugs
| Trulicity | 829 | $959,415 | $1,157 |
| Novolog Flexpen | 589 | $672,035 | $1,141 |
| Victoza 3-Pak | 373 | $522,404 | $1,401 |
| Jardiance | 401 | $406,851 | $1,015 |
| Forteo | 90 | $333,334 | $3,704 |
| Humalog Kwikpen U-100 | 293 | $304,644 | $1,040 |
| Tradjenta | 327 | $272,088 | $832 |
| Ozempic | 210 | $259,497 | $1,236 |
| Invokana | 290 | $233,162 | $804 |
| Lantus Solostar | 372 | $198,779 | $534 |
| Januvia | 238 | $193,833 | $814 |
| Bydureon Bcise | 161 | $187,184 | $1,163 |
| Prolia | 133 | $163,705 | $1,231 |
| Toujeo Solostar | 250 | $155,818 | $623 |
| Farxiga | 147 | $138,867 | $945 |
| Humalog Kwikpen U-200 | 48 | $116,664 | $2,430 |
| Sensipar | 50 | $91,698 | $1,834 |
| Tymlos | 36 | $79,747 | $2,215 |
| Repatha Sureclick | 84 | $70,243 | $836 |
| Tresiba Flextouch U-100 | 116 | $62,970 | $543 |
| Victoza 2-Pak | 45 | $58,187 | $1,293 |
| Bydureon | 66 | $58,083 | $880 |
| Tresiba Flextouch U-200 | 61 | $55,246 | $906 |
| Humalog | 58 | $50,397 | $869 |
| Praluent | 52 | $50,259 | $967 |
| Ultra-Fine Nano Pen Needle | 584 | $49,319 | $84 |
| Basaglar Kwikpen U-100 | 165 | $48,504 | $294 |
| Vascepa | 87 | $45,900 | $528 |
| Toujeo Max Solostar | 39 | $43,204 | $1,108 |
| Repaglinide | 346 | $40,197 | $116 |
| Cinacalcet | 35 | $39,547 | $1,130 |
| Afrezza | 26 | $34,538 | $1,328 |
| Synjardy | 30 | $31,396 | $1,047 |
| Xigduo Xr | 37 | $30,503 | $824 |
| Testosterone | 66 | $30,255 | $458 |
| Janumet | 42 | $26,862 | $640 |
| Levothyroxine | 970 | $24,401 | $25 |
| Invokamet | 39 | $24,297 | $623 |
| Synjardy Xr | 19 | $23,110 | $1,216 |
| Nateglinide | 164 | $21,629 | $132 |
| Levemir Flextouch | 39 | $21,306 | $546 |
| Synthroid | 247 | $21,055 | $85 |
| Prandin | 14 | $20,388 | $1,456 |
| Repatha Pushtronex | 14 | $15,885 | $1,135 |
| Janumet Xr | 27 | $14,612 | $541 |
| Lantus | 25 | $14,273 | $571 |
| Xultophy 100-3.6 | 31 | $14,219 | $459 |
| Easy Comfort Pen Needles | 119 | $14,031 | $118 |
| Novolog | 14 | $14,025 | $1,002 |
| Onglyza | 21 | $13,591 | $647 |
| Rosuvastatin | 162 | $11,281 | $70 |
| Jentadueto | 14 | $10,696 | $764 |
| Ultracare Pen Needle | 91 | $10,268 | $113 |
| Tirosint | 40 | $9,870 | $247 |
| Admelog Solostar | 13 | $8,940 | $688 |
| Ulticare Pen Needle | 123 | $8,464 | $69 |
| Atorvastatin | 470 | $8,268 | $18 |
| Olmesartan Medoxomil | 76 | $8,072 | $106 |
| Comfort Ez Pen Needle | 47 | $7,734 | $165 |
| Metformin | 893 | $7,657 | $9 |
| Pioglitazone | 362 | $7,262 | $20 |
| Kombiglyze Xr | 13 | $7,253 | $558 |
| Glucagon Emergency Kit | 12 | $6,766 | $564 |
| Metformin Hcl Er | 277 | $4,982 | $18 |
| Ezetimibe | 90 | $4,982 | $55 |
| Alcohol Prep Pads | 37 | $4,817 | $130 |
| Ultra-Fine Mini Pen Needle | 79 | $4,441 | $56 |
| Ultra-Fine Short Pen Needle | 57 | $3,870 | $68 |
| Alcohol Pads | 72 | $3,843 | $53 |
| Easy Comfort Pen Needle | 24 | $3,334 | $139 |
| Omega-3 Acid Ethyl Esters | 19 | $3,242 | $171 |
| Hydrocortisone | 64 | $3,022 | $47 |
| Losartan | 271 | $2,877 | $11 |
| Edarbi | 13 | $2,811 | $216 |
| Valsartan | 31 | $2,737 | $88 |
| Methimazole | 180 | $2,645 | $15 |
| Alendronate | 269 | $2,232 | $8 |
| Amlodipine Besylate | 280 | $2,211 | $8 |
| Testosterone Cypionate | 93 | $2,187 | $24 |
| Fenofibrate | 30 | $2,109 | $70 |
| Irbesartan | 46 | $2,018 | $44 |
| Risedronate | 23 | $1,878 | $82 |
| Gabapentin | 98 | $1,745 | $18 |
| Calcitriol | 39 | $1,678 | $43 |
| Metoprolol | 56 | $1,656 | $30 |
| Nano 2nd Gen Pen Needle | 13 | $1,555 | $120 |
| Olmesartan-Hydrochlorothiazide | 24 | $1,554 | $65 |
| Simvastatin | 178 | $1,391 | $8 |
| Easy Touch Pen Needle | 52 | $1,370 | $26 |
| Lisinopril | 156 | $1,355 | $9 |
| Pravastatin | 78 | $1,346 | $17 |
| Hydrochlorothiazide | 170 | $1,295 | $8 |
| Fenofibric Acid | 12 | $1,228 | $102 |
| Novofine 32 | 17 | $1,176 | $69 |
| Unifine Pentips | 50 | $1,138 | $23 |
| Novofine Plus | 12 | $1,088 | $91 |
| Losartan-Hydrochlorothiazide | 81 | $930 | $11 |
| Glipizide | 81 | $768 | $9 |
| Glimepiride | 44 | $632 | $14 |
| Carvedilol | 62 | $571 | $9 |
| Valsartan-Hydrochlorothiazide | 17 | $570 | $34 |
| Telmisartan | 11 | $561 | $51 |
| Irbesartan-Hydrochlorothiazide | 12 | $522 | $44 |
| Atenolol | 65 | $509 | $8 |
| Omeprazole | 31 | $497 | $16 |
| Potassium Chloride | 12 | $343 | $29 |
| Trueplus Pen Needle | 12 | $305 | $25 |
| Enalapril Maleate | 12 | $263 | $22 |
| Benazepril | 28 | $260 | $9 |
| Metoprolol | 49 | $247 | $5 |
| Fosinopril | 17 | $236 | $14 |
| Fludrocortisone Acetate | 12 | $213 | $18 |
| Prednisone | 12 | $162 | $13 |
| Fluconazole | 33 | $156 | $5 |
| Furosemide | 21 | $115 | $5 |
| Ramipril | 12 | $78 | $7 |
2018: 126 drugs
| Victoza 3-Pak | 499 | $507,265 | $1,017 |
| Novolog Flexpen | 476 | $483,692 | $1,016 |
| Trulicity | 452 | $446,266 | $987 |
| Forteo | 102 | $348,144 | $3,413 |
| Humalog Kwikpen U-100 | 377 | $315,451 | $837 |
| Tradjenta | 356 | $225,654 | $634 |
| Invokana | 335 | $206,746 | $617 |
| Januvia | 294 | $204,902 | $697 |
| Lantus Solostar | 438 | $199,297 | $455 |
| Jardiance | 264 | $178,796 | $677 |
| Toujeo Solostar | 236 | $132,772 | $563 |
| Prolia | 104 | $122,120 | $1,174 |
| Farxiga | 158 | $109,501 | $693 |
| Humalog Kwikpen U-200 | 46 | $99,083 | $2,154 |
| Bydureon Bcise | 102 | $94,174 | $923 |
| Sensipar | 46 | $78,695 | $1,711 |
| Tresiba Flextouch U-200 | 68 | $75,139 | $1,105 |
| Enbrel | 13 | $61,494 | $4,730 |
| Bydureon | 72 | $52,510 | $729 |
| Androgel | 61 | $52,013 | $853 |
| Victoza 2-Pak | 67 | $50,904 | $760 |
| Repatha Sureclick | 41 | $49,443 | $1,206 |
| Tresiba Flextouch U-100 | 83 | $45,359 | $546 |
| Basaglar Kwikpen U-100 | 129 | $45,070 | $349 |
| Ultra-Fine Nano Pen Needle | 619 | $43,346 | $70 |
| Humalog | 58 | $40,998 | $707 |
| Praluent | 35 | $39,960 | $1,142 |
| Repaglinide | 328 | $35,071 | $107 |
| Tymlos | 17 | $29,405 | $1,730 |
| Janumet | 40 | $29,106 | $728 |
| Invokamet | 44 | $26,394 | $600 |
| Levothyroxine | 1,149 | $23,956 | $21 |
| Levemir Flextouch | 57 | $21,628 | $379 |
| Nateglinide | 169 | $20,369 | $121 |
| Apidra Solostar | 18 | $20,118 | $1,118 |
| Synthroid | 312 | $19,163 | $61 |
| Ozempic | 25 | $19,077 | $763 |
| Prandin | 14 | $18,331 | $1,309 |
| Onglyza | 27 | $17,279 | $640 |
| Lyrica | 26 | $15,785 | $607 |
| Jentadueto | 16 | $14,943 | $934 |
| Soliqua 100-33 | 13 | $13,623 | $1,048 |
| Invokamet Xr | 11 | $13,192 | $1,199 |
| Easy Comfort Pen Needles | 128 | $12,893 | $101 |
| Symlinpen 120 | 12 | $12,732 | $1,061 |
| Synjardy Xr | 18 | $12,299 | $683 |
| Ezetimibe | 91 | $11,552 | $127 |
| Ulticare Pen Needle | 186 | $10,629 | $57 |
| Vascepa | 20 | $10,476 | $524 |
| Bydureon | 15 | $10,367 | $691 |
| Tanzeum | 14 | $10,271 | $734 |
| Androderm | 23 | $9,961 | $433 |
| Welchol | 16 | $9,899 | $619 |
| Byetta | 12 | $9,549 | $796 |
| Rosuvastatin | 175 | $8,642 | $49 |
| Janumet Xr | 16 | $8,518 | $532 |
| Xigduo Xr | 17 | $8,392 | $494 |
| Synjardy | 15 | $8,281 | $552 |
| Kombiglyze Xr | 21 | $8,156 | $388 |
| Tirosint | 53 | $7,973 | $150 |
| Lantus | 21 | $7,897 | $376 |
| Omega-3 Acid Ethyl Esters | 49 | $7,666 | $156 |
| Metformin | 816 | $7,489 | $9 |
| Atorvastatin | 417 | $6,501 | $16 |
| Valsartan | 133 | $6,327 | $48 |
| Pioglitazone | 407 | $6,242 | $15 |
| Ultra-Fine Short Pen Needle | 94 | $5,478 | $58 |
| Alcohol Pads | 103 | $5,254 | $51 |
| Ultra-Fine Mini Pen Needle | 99 | $4,688 | $47 |
| Olmesartan Medoxomil | 46 | $4,171 | $91 |
| Metformin Hcl Er | 244 | $4,007 | $16 |
| Easy Comfort Pen Needle | 36 | $3,656 | $102 |
| Lovaza | 12 | $3,385 | $282 |
| Hydrocortisone | 74 | $3,259 | $44 |
| Alendronate | 352 | $2,603 | $7 |
| Testosterone Cypionate | 96 | $2,560 | $27 |
| Calcitriol | 36 | $2,103 | $58 |
| Fenofibrate | 53 | $2,085 | $39 |
| Amlodipine Besylate | 325 | $2,059 | $6 |
| Methimazole | 168 | $1,942 | $12 |
| Losartan | 211 | $1,919 | $9 |
| Novofine 32 | 23 | $1,764 | $77 |
| Fenofibric Acid | 17 | $1,700 | $100 |
| Pravastatin | 86 | $1,575 | $18 |
| Metoprolol | 59 | $1,488 | $25 |
| Simvastatin | 209 | $1,473 | $7 |
| Gabapentin | 64 | $1,428 | $22 |
| Valsartan-Hydrochlorothiazide | 59 | $1,405 | $24 |
| Glimepiride | 53 | $1,297 | $24 |
| Unifine Pentips | 62 | $1,292 | $21 |
| Hydrochlorothiazide | 193 | $1,176 | $6 |
| Lisinopril | 145 | $1,168 | $8 |
| Irbesartan-Hydrochlorothiazide | 21 | $1,025 | $49 |
| Easy Touch Pen Needle | 33 | $912 | $28 |
| Losartan-Hydrochlorothiazide | 72 | $814 | $11 |
| Sure Comfort | 25 | $778 | $31 |
| Irbesartan | 29 | $772 | $27 |
| Glipizide | 82 | $745 | $9 |
| Metoprolol | 55 | $610 | $11 |
| Omeprazole | 46 | $573 | $12 |
| Telmisartan | 12 | $548 | $46 |
| Prednisone | 26 | $525 | $20 |
| Trueplus Pen Needle | 18 | $519 | $29 |
| Insulin | 19 | $474 | $25 |
| Spironolactone | 18 | $445 | $25 |
| Fenofibrate | 12 | $422 | $35 |
| Carvedilol | 64 | $416 | $6 |
| Atenolol | 52 | $360 | $7 |
| Unifine Pentips Plus | 12 | $359 | $30 |
| Enalapril Maleate | 17 | $310 | $18 |
| Fludrocortisone Acetate | 12 | $297 | $25 |
| Clopidogrel | 20 | $293 | $15 |
| Benazepril | 39 | $254 | $7 |
| Insulin | 11 | $246 | $22 |
| Nifedipine Er | 11 | $208 | $19 |
| Tamsulosin | 18 | $182 | $10 |
| Fluconazole | 21 | $166 | $8 |
| Fosinopril | 22 | $143 | $7 |
| Fluticasone Propionate | 12 | $132 | $11 |
| Oxybutynin Chloride | 12 | $128 | $11 |
| Lovastatin | 17 | $98 | $6 |
| Ramipril | 19 | $94 | $5 |
| Citalopram Hbr | 15 | $89 | $6 |
| Furosemide | 13 | $30 | $2 |
| Verapamil | 12 | $21 | $2 |
| Dexamethasone | 17 | $19 | $1 |
2017: 120 drugs
| Novolog Flexpen | 450 | $379,870 | $844 |
| Humalog Kwikpen U-100 | 373 | $316,109 | $847 |
| Victoza 3-Pak | 323 | $282,479 | $875 |
| Januvia | 421 | $233,487 | $555 |
| Lantus Solostar | 519 | $196,905 | $379 |
| Invokana | 360 | $181,852 | $505 |
| Tradjenta | 386 | $176,382 | $457 |
| Forteo | 50 | $148,068 | $2,961 |
| Trulicity | 187 | $142,676 | $763 |
| Prolia | 105 | $115,677 | $1,102 |
| Toujeo Solostar | 238 | $113,847 | $478 |
| Humalog Kwikpen U-200 | 47 | $94,582 | $2,012 |
| Tresiba Flextouch U-200 | 63 | $74,381 | $1,181 |
| Bydureon | 98 | $68,702 | $701 |
| Jardiance | 126 | $63,835 | $507 |
| Androgel | 80 | $62,915 | $786 |
| Enbrel | 14 | $60,605 | $4,329 |
| Farxiga | 117 | $57,596 | $492 |
| Victoza 2-Pak | 70 | $53,795 | $768 |
| Janumet | 74 | $35,752 | $483 |
| Invokamet | 77 | $34,165 | $444 |
| Sensipar | 17 | $31,216 | $1,836 |
| Ultra-Fine Nano Pen Needle | 531 | $30,663 | $58 |
| Repaglinide | 349 | $28,843 | $83 |
| Lantus | 51 | $28,596 | $561 |
| Onglyza | 56 | $27,004 | $482 |
| Humalog | 51 | $26,600 | $522 |
| Levemir Flextouch | 83 | $25,127 | $303 |
| Levothyroxine | 1,183 | $21,273 | $18 |
| Welchol | 34 | $21,225 | $624 |
| Nateglinide | 200 | $20,834 | $104 |
| Tresiba Flextouch U-100 | 26 | $19,841 | $763 |
| Praluent | 16 | $18,154 | $1,135 |
| Prandin | 15 | $17,042 | $1,136 |
| Bydureon | 18 | $16,216 | $901 |
| Novolog | 14 | $16,034 | $1,145 |
| Synthroid | 326 | $14,994 | $46 |
| Kombiglyze Xr | 33 | $14,081 | $427 |
| Metformin Hcl Er | 217 | $13,969 | $64 |
| Repatha Sureclick | 12 | $13,445 | $1,120 |
| Omega-3 Acid Ethyl Esters | 74 | $12,833 | $173 |
| Jentadueto | 14 | $12,768 | $912 |
| Crestor | 23 | $12,457 | $542 |
| Vascepa | 32 | $10,132 | $317 |
| Lyrica | 18 | $9,759 | $542 |
| Valsartan | 239 | $9,532 | $40 |
| Ezetimibe | 38 | $8,569 | $225 |
| Cycloset | 15 | $8,470 | $565 |
| Tanzeum | 11 | $8,395 | $763 |
| Rosuvastatin | 179 | $8,298 | $46 |
| Byetta | 12 | $7,849 | $654 |
| Ulticare Pen Needle | 153 | $7,774 | $51 |
| Ultra-Fine Short Pen Needle | 121 | $6,318 | $52 |
| Tirosint | 44 | $6,133 | $139 |
| Metformin | 785 | $6,101 | $8 |
| Pioglitazone | 388 | $6,063 | $16 |
| Androderm | 14 | $5,240 | $374 |
| Ultra-Fine Mini Pen Needle | 97 | $5,187 | $53 |
| Atorvastatin | 399 | $4,820 | $12 |
| Hydrocortisone | 102 | $4,406 | $43 |
| Easy Comfort Pen Needles | 36 | $4,319 | $120 |
| Janumet Xr | 11 | $4,235 | $385 |
| Lovaza | 12 | $3,417 | $285 |
| Sure Comfort | 97 | $2,980 | $31 |
| Alendronate | 359 | $2,694 | $8 |
| Unifine Pentips | 101 | $2,539 | $25 |
| Alcohol Pads | 52 | $2,439 | $47 |
| Bd Ultra-Fine Pen Needle | 24 | $2,286 | $95 |
| Bromocriptine Mesylate | 11 | $2,260 | $205 |
| Fenofibrate | 56 | $2,142 | $38 |
| Desmopressin Acetate | 11 | $2,122 | $193 |
| Valsartan-Hydrochlorothiazide | 93 | $1,922 | $21 |
| Testosterone Cypionate | 63 | $1,822 | $29 |
| Amlodipine Besylate | 295 | $1,780 | $6 |
| Methimazole | 200 | $1,704 | $9 |
| Calcitriol | 33 | $1,660 | $50 |
| Novofine Plus | 13 | $1,589 | $122 |
| Novofine 32 | 28 | $1,501 | $54 |
| Methotrexate | 18 | $1,489 | $83 |
| Pravastatin | 104 | $1,479 | $14 |
| Losartan | 228 | $1,399 | $6 |
| Simvastatin | 235 | $1,380 | $6 |
| Fenofibric Acid | 17 | $1,339 | $79 |
| Hydrochlorothiazide | 199 | $1,271 | $6 |
| Insulin | 41 | $1,149 | $28 |
| Glimepiride | 70 | $1,068 | $15 |
| Irbesartan-Hydrochlorothiazide | 12 | $910 | $76 |
| Metoprolol | 41 | $819 | $20 |
| Lisinopril | 133 | $776 | $6 |
| Glipizide | 110 | $759 | $7 |
| Gabapentin | 67 | $711 | $11 |
| Fenofibrate | 22 | $661 | $30 |
| Easy Touch Pen Needle | 21 | $644 | $31 |
| Spironolactone | 17 | $643 | $38 |
| Alcohol Prep Pads | 13 | $596 | $46 |
| Enalapril Maleate | 25 | $545 | $22 |
| Ultra-Fine Original Pen Needle | 12 | $486 | $41 |
| Losartan-Hydrochlorothiazide | 44 | $483 | $11 |
| Irbesartan | 14 | $456 | $33 |
| Unifine Pentips Plus | 19 | $454 | $24 |
| Propylthiouracil | 11 | $426 | $39 |
| Omeprazole | 43 | $416 | $10 |
| Prednisone | 31 | $405 | $13 |
| Triamcinolone Acetonide | 12 | $377 | $31 |
| Insulin | 15 | $305 | $20 |
| Benazepril | 70 | $295 | $4 |
| Atenolol | 53 | $277 | $5 |
| Carvedilol | 53 | $266 | $5 |
| Tamsulosin | 13 | $242 | $19 |
| Metoprolol | 55 | $232 | $4 |
| Fluconazole | 17 | $225 | $13 |
| Ramipril | 24 | $201 | $8 |
| Fosinopril | 22 | $198 | $9 |
| Lisinopril-Hydrochlorothiazide | 16 | $185 | $12 |
| Clopidogrel | 13 | $174 | $13 |
| Lovastatin | 20 | $172 | $9 |
| Glyburide | 12 | $125 | $10 |
| Citalopram Hbr | 18 | $61 | $3 |
| Furosemide | 23 | $56 | $2 |
| Verapamil | 11 | $18 | $2 |
2016: 117 drugs
| Humalog Kwikpen U-100 | 397 | $304,573 | $767 |
| Novolog Flexpen | 431 | $293,225 | $680 |
| Forteo | 91 | $243,413 | $2,675 |
| Lantus Solostar | 634 | $225,746 | $356 |
| Januvia | 504 | $225,615 | $448 |
| Tradjenta | 389 | $165,119 | $424 |
| Invokana | 345 | $153,329 | $444 |
| Victoza 3-Pak | 166 | $144,341 | $870 |
| Prolia | 128 | $129,195 | $1,009 |
| Toujeo Solostar | 177 | $87,690 | $495 |
| Bydureon | 110 | $64,703 | $588 |
| Trulicity | 91 | $59,825 | $657 |
| Levemir Flextouch | 129 | $49,105 | $381 |
| Tresiba Flextouch U-200 | 34 | $46,560 | $1,369 |
| Enbrel | 11 | $44,848 | $4,077 |
| Lantus | 76 | $42,840 | $564 |
| Bd Ultra-Fine Pen Needle | 784 | $40,232 | $51 |
| Janumet | 88 | $38,875 | $442 |
| Victoza 2-Pak | 71 | $36,088 | $508 |
| Onglyza | 70 | $32,831 | $469 |
| Crestor | 113 | $32,255 | $285 |
| Androgel | 53 | $31,410 | $593 |
| Praluent | 23 | $28,612 | $1,244 |
| Repaglinide | 311 | $24,416 | $79 |
| Humalog Kwikpen U-200 | 19 | $24,121 | $1,270 |
| Nateglinide | 245 | $23,725 | $97 |
| Humalog | 47 | $23,543 | $501 |
| Jardiance | 52 | $23,300 | $448 |
| Metformin Hcl Er | 189 | $23,263 | $123 |
| Farxiga | 51 | $22,979 | $451 |
| Apidra Solostar | 21 | $22,050 | $1,050 |
| Invokamet | 56 | $21,930 | $392 |
| Tresiba Flextouch U-100 | 34 | $20,675 | $608 |
| Symlinpen 60 | 12 | $19,107 | $1,592 |
| Omega-3 Acid Ethyl Esters | 110 | $18,973 | $172 |
| Levothyroxine | 1,071 | $17,240 | $16 |
| Humulin R U-500 | 11 | $16,973 | $1,543 |
| Kombiglyze Xr | 40 | $16,164 | $404 |
| Welchol | 21 | $15,158 | $722 |
| Prandin | 14 | $15,112 | $1,079 |
| Zetia | 44 | $13,420 | $305 |
| Vascepa | 53 | $12,609 | $238 |
| Synthroid | 285 | $12,602 | $44 |
| Bydureon | 19 | $12,134 | $639 |
| Cycloset | 22 | $11,979 | $544 |
| Novolog | 17 | $10,655 | $627 |
| Levemir | 12 | $10,031 | $836 |
| Novolog Mix 70-30 Flexpen | 12 | $10,016 | $835 |
| Pioglitazone | 406 | $8,178 | $20 |
| Pioglitazone-Metformin | 22 | $7,939 | $361 |
| Janumet Xr | 23 | $7,733 | $336 |
| Valsartan | 182 | $7,482 | $41 |
| Jentadueto | 14 | $7,034 | $502 |
| Metformin | 888 | $6,447 | $7 |
| Ulticare Pen Needle | 147 | $6,257 | $43 |
| Tirosint | 34 | $4,987 | $147 |
| Atorvastatin | 407 | $4,755 | $12 |
| Livalo | 18 | $4,338 | $241 |
| Hydrocortisone | 85 | $3,804 | $45 |
| Sure Comfort | 100 | $3,325 | $33 |
| Rosuvastatin | 45 | $3,116 | $69 |
| Glucagon Emergency Kit | 11 | $3,059 | $278 |
| Fenofibrate | 67 | $3,007 | $45 |
| Unifine Pentips | 108 | $2,947 | $27 |
| Benicar Hct | 12 | $2,764 | $230 |
| Tribenzor | 14 | $2,740 | $196 |
| Humulin R | 13 | $2,634 | $203 |
| Methimazole | 265 | $2,319 | $9 |
| Bromocriptine Mesylate | 18 | $2,007 | $112 |
| Alendronate | 325 | $1,974 | $6 |
| Pravastatin | 105 | $1,927 | $18 |
| Novofine 32 | 32 | $1,917 | $60 |
| Losartan | 299 | $1,904 | $6 |
| Valsartan-Hydrochlorothiazide | 96 | $1,817 | $19 |
| Easy Touch Pen Needle | 42 | $1,644 | $39 |
| Simvastatin | 293 | $1,517 | $5 |
| Desmopressin Acetate | 13 | $1,510 | $116 |
| Amlodipine Besylate | 233 | $1,483 | $6 |
| Telmisartan-Hydrochlorothiazid | 13 | $1,422 | $109 |
| Glimepiride | 94 | $1,354 | $14 |
| Fenofibric Acid | 13 | $1,318 | $101 |
| Calcitriol | 37 | $1,150 | $31 |
| Irbesartan-Hydrochlorothiazide | 13 | $1,118 | $86 |
| Metoprolol | 35 | $1,084 | $31 |
| Alcohol Prep Pads | 13 | $1,064 | $82 |
| Insulin | 38 | $1,031 | $27 |
| Testosterone Cypionate | 32 | $959 | $30 |
| Unifine Pentips Plus | 30 | $880 | $29 |
| Gabapentin | 67 | $816 | $12 |
| Glipizide | 165 | $802 | $5 |
| Lisinopril | 120 | $728 | $6 |
| Hydrochlorothiazide | 139 | $725 | $5 |
| Insulin | 31 | $620 | $20 |
| Enalapril Maleate | 25 | $512 | $20 |
| Methotrexate | 13 | $489 | $38 |
| Benazepril | 94 | $473 | $5 |
| Omeprazole | 50 | $458 | $9 |
| Ramipril | 25 | $458 | $18 |
| Propylthiouracil | 12 | $442 | $37 |
| Quinapril-Hydrochlorothiazide | 12 | $354 | $30 |
| Metoprolol | 40 | $304 | $8 |
| Atenolol | 48 | $281 | $6 |
| Losartan-Hydrochlorothiazide | 35 | $280 | $8 |
| Fosinopril | 16 | $255 | $16 |
| Carvedilol | 51 | $241 | $5 |
| Triamcinolone Acetonide | 13 | $227 | $17 |
| Ranitidine | 11 | $175 | $16 |
| Irbesartan | 13 | $155 | $12 |
| Quinapril | 14 | $149 | $11 |
| Lovastatin | 30 | $142 | $5 |
| Prednisone | 17 | $124 | $7 |
| Clopidogrel | 11 | $118 | $11 |
| Verapamil | 12 | $72 | $6 |
| Fluconazole | 13 | $56 | $4 |
| Citalopram Hbr | 18 | $50 | $3 |
| Furosemide | 12 | $27 | $2 |
| Zolpidem | 11 | $17 | $2 |
2015: 109 drugs
| Novolog Flexpen | 446 | $290,974 | $652 |
| Humalog Kwikpen U-100 | 392 | $283,302 | $723 |
| Lantus Solostar | 685 | $274,324 | $400 |
| Forteo | 108 | $227,042 | $2,102 |
| Januvia | 436 | $188,217 | $432 |
| Tradjenta | 318 | $119,865 | $377 |
| Prolia | 110 | $102,801 | $935 |
| Invokana | 231 | $89,836 | $389 |
| Victoza 3-Pak | 80 | $61,459 | $768 |
| Levemir Flextouch | 156 | $60,749 | $389 |
| Lantus | 103 | $59,076 | $574 |
| Repaglinide | 240 | $42,386 | $177 |
| Androgel | 64 | $41,487 | $648 |
| Crestor | 148 | $40,050 | $271 |
| Bd Ultra-Fine Pen Needle | 806 | $40,041 | $50 |
| Victoza 2-Pak | 85 | $37,144 | $437 |
| Bydureon | 64 | $35,322 | $552 |
| Onglyza | 86 | $33,354 | $388 |
| Humalog | 68 | $26,992 | $397 |
| Bydureon | 42 | $24,908 | $593 |
| Prandin | 27 | $24,753 | $917 |
| Symlinpen 60 | 19 | $23,439 | $1,234 |
| Janumet | 61 | $22,855 | $375 |
| Nateglinide | 207 | $22,236 | $107 |
| Levemir | 22 | $22,191 | $1,009 |
| Apidra Solostar | 30 | $21,956 | $732 |
| Glumetza | 13 | $18,997 | $1,461 |
| Cycloset | 30 | $15,804 | $527 |
| Novolog | 21 | $15,734 | $749 |
| Welchol | 26 | $15,117 | $581 |
| Levothyroxine | 1,009 | $15,039 | $15 |
| Omega-3 Acid Ethyl Esters | 66 | $13,656 | $207 |
| Farxiga | 34 | $12,955 | $381 |
| Pioglitazone | 395 | $11,962 | $30 |
| Synthroid | 286 | $10,944 | $38 |
| Sensipar | 14 | $10,502 | $750 |
| Zetia | 44 | $10,286 | $234 |
| Kombiglyze Xr | 32 | $10,205 | $319 |
| Pioglitazone-Metformin | 29 | $9,747 | $336 |
| Byetta | 15 | $9,234 | $616 |
| Valsartan | 82 | $8,054 | $98 |
| Janumet Xr | 25 | $6,677 | $267 |
| Toujeo Solostar | 18 | $6,599 | $367 |
| Ulticare | 146 | $6,334 | $43 |
| Metformin | 756 | $5,975 | $8 |
| Fenofibrate | 67 | $5,757 | $86 |
| Vascepa | 26 | $5,692 | $219 |
| Metformin Hcl Er | 54 | $5,653 | $105 |
| Amitiza | 16 | $5,381 | $336 |
| Invokamet | 13 | $4,781 | $368 |
| Lovaza | 16 | $4,248 | $266 |
| Livalo | 17 | $4,228 | $249 |
| Atorvastatin | 256 | $3,464 | $14 |
| Tirosint | 25 | $3,419 | $137 |
| Risedronate | 19 | $3,312 | $174 |
| Hydrocortisone | 78 | $3,158 | $40 |
| Diovan | 12 | $3,108 | $259 |
| Fenofibric Acid | 34 | $2,957 | $87 |
| Sure Comfort | 82 | $2,771 | $34 |
| Levemir Flexpen | 15 | $2,700 | $180 |
| Benicar Hct | 11 | $2,628 | $239 |
| Methimazole | 247 | $2,627 | $11 |
| Valsartan-Hydrochlorothiazide | 73 | $2,437 | $33 |
| Telmisartan-Hydrochlorothiazid | 21 | $2,293 | $109 |
| Alendronate | 335 | $2,277 | $7 |
| Tribenzor | 12 | $2,201 | $183 |
| Pravastatin | 86 | $2,000 | $23 |
| Namenda | 11 | $1,901 | $173 |
| Calcitriol | 49 | $1,888 | $39 |
| Unifine Pentips | 65 | $1,866 | $29 |
| Bromocriptine Mesylate | 20 | $1,801 | $90 |
| Losartan | 273 | $1,781 | $7 |
| Amlodipine Besylate | 235 | $1,387 | $6 |
| Easy Touch Pen Needle | 30 | $1,318 | $44 |
| Simvastatin | 264 | $1,153 | $4 |
| Acarbose | 15 | $1,151 | $77 |
| Insulin | 33 | $1,045 | $32 |
| Insulin | 44 | $995 | $23 |
| Novofine 32 | 20 | $888 | $44 |
| Glimepiride | 72 | $851 | $12 |
| Hydrochlorothiazide | 134 | $847 | $6 |
| Glipizide | 159 | $777 | $5 |
| Gabapentin | 50 | $728 | $15 |
| Ramipril | 28 | $727 | $26 |
| Testosterone Cypionate | 16 | $722 | $45 |
| Lisinopril | 121 | $690 | $6 |
| Metoprolol | 22 | $688 | $31 |
| Omeprazole | 68 | $585 | $9 |
| Propylthiouracil | 13 | $533 | $41 |
| Quinapril | 16 | $475 | $30 |
| Enalapril Maleate | 22 | $429 | $19 |
| Quinapril-Hydrochlorothiazide | 11 | $422 | $38 |
| Insulin | 22 | $415 | $19 |
| Losartan-Hydrochlorothiazide | 34 | $380 | $11 |
| Metoprolol | 79 | $357 | $5 |
| Liothyronine | 11 | $347 | $32 |
| Atenolol | 50 | $319 | $6 |
| Benazepril | 76 | $317 | $4 |
| Triamcinolone Acetonide | 17 | $292 | $17 |
| Ranitidine | 12 | $231 | $19 |
| Relion Pen Needles | 11 | $183 | $17 |
| Carvedilol | 23 | $159 | $7 |
| Prednisone | 16 | $157 | $10 |
| Allopurinol | 11 | $149 | $14 |
| Lovastatin | 26 | $145 | $6 |
| Furosemide | 34 | $137 | $4 |
| Fluconazole | 12 | $86 | $7 |
| Citalopram Hbr | 16 | $80 | $5 |
| Verapamil | 12 | $60 | $5 |
2014: 107 drugs
| Novolog Flexpen | 421 | $256,110 | $608 |
| Lantus Solostar | 670 | $241,715 | $361 |
| Humalog | 428 | $237,149 | $554 |
| Forteo | 132 | $220,156 | $1,668 |
| Januvia | 425 | $165,601 | $390 |
| Prolia | 125 | $109,192 | $874 |
| Tradjenta | 215 | $81,189 | $378 |
| Lantus | 140 | $72,103 | $515 |
| Invokana | 154 | $51,491 | $334 |
| Repaglinide | 196 | $42,725 | $218 |
| Prandin | 50 | $42,412 | $848 |
| Crestor | 169 | $40,908 | $242 |
| Bd Ultra-Fine Pen Needle | 862 | $39,634 | $46 |
| Onglyza | 109 | $37,673 | $346 |
| Androgel | 63 | $34,150 | $542 |
| Victoza 3-Pak | 43 | $30,288 | $704 |
| Levemir Flexpen | 85 | $28,241 | $332 |
| Nateglinide | 198 | $26,434 | $134 |
| Byetta | 48 | $23,530 | $490 |
| Diovan | 106 | $23,217 | $219 |
| Pioglitazone | 329 | $21,563 | $66 |
| Bydureon | 47 | $21,096 | $449 |
| Novolog | 34 | $20,435 | $601 |
| Cycloset | 42 | $17,260 | $411 |
| Glumetza | 17 | $16,257 | $956 |
| Lovaza | 53 | $15,874 | $300 |
| Victoza 2-Pak | 39 | $15,285 | $392 |
| Levothyroxine | 1,006 | $13,198 | $13 |
| Janumet | 30 | $11,028 | $368 |
| Pioglitazone-Metformin | 30 | $10,726 | $358 |
| Welchol | 27 | $10,286 | $381 |
| Synthroid | 335 | $9,938 | $30 |
| Kombiglyze Xr | 26 | $9,805 | $377 |
| Symlinpen 60 | 13 | $9,634 | $741 |
| Actonel | 27 | $8,738 | $324 |
| Farxiga | 21 | $7,882 | $375 |
| Zetia | 37 | $7,019 | $190 |
| Metformin Hcl Er | 51 | $6,915 | $136 |
| Levemir Flextouch | 11 | $6,594 | $599 |
| Novolog Mix 70-30 Flexpen | 11 | $6,363 | $578 |
| Metformin | 659 | $6,265 | $10 |
| Janumet Xr | 22 | $6,140 | $279 |
| Ulticare | 126 | $5,820 | $46 |
| Apidra Solostar | 14 | $5,767 | $412 |
| Fenofibrate | 49 | $5,243 | $107 |
| Vascepa | 26 | $5,225 | $201 |
| Fenofibric Acid | 45 | $5,182 | $115 |
| Niacin Er | 28 | $5,063 | $181 |
| Valsartan-Hydrochlorothiazide | 79 | $4,251 | $54 |
| Atorvastatin | 273 | $4,118 | $15 |
| Fortesta | 11 | $4,000 | $364 |
| Tirosint | 34 | $3,705 | $109 |
| Sure Comfort | 101 | $3,595 | $36 |
| Valsartan | 19 | $3,412 | $180 |
| Alendronate | 385 | $3,124 | $8 |
| Benicar Hct | 16 | $3,005 | $188 |
| Omega-3 Acid Ethyl Esters | 14 | $2,949 | $211 |
| Hydrocortisone | 74 | $2,820 | $38 |
| Glucagon Emergency Kit | 15 | $2,685 | $179 |
| Atelvia | 14 | $2,596 | $185 |
| Methimazole | 219 | $2,548 | $12 |
| Losartan | 250 | $2,023 | $8 |
| Pravastatin | 90 | $2,021 | $22 |
| Dexilant | 11 | $1,956 | $178 |
| Simvastatin | 297 | $1,946 | $7 |
| Bystolic | 15 | $1,817 | $121 |
| Amlodipine Besylate | 207 | $1,770 | $9 |
| Calcitriol | 39 | $1,733 | $44 |
| Telmisartan-Hydrochlorothiazid | 15 | $1,708 | $114 |
| Unifine Pentips | 36 | $1,186 | $33 |
| Ibandronate | 12 | $1,181 | $98 |
| Bromocriptine Mesylate | 14 | $1,172 | $84 |
| Easy Touch Pen Needle | 30 | $1,102 | $37 |
| Hydrochlorothiazide | 170 | $1,041 | $6 |
| Insulin | 39 | $978 | $25 |
| Lisinopril | 142 | $976 | $7 |
| Omeprazole | 79 | $961 | $12 |
| Glimepiride | 81 | $947 | $12 |
| Glipizide | 130 | $926 | $7 |
| Glyburide | 25 | $785 | $31 |
| Metoprolol | 27 | $782 | $29 |
| Testosterone Cypionate | 14 | $761 | $54 |
| Amlodipine Besylate-Benazepril | 12 | $735 | $61 |
| Ramipril | 34 | $655 | $19 |
| Gabapentin | 34 | $561 | $16 |
| Insulin | 16 | $535 | $33 |
| Insulin | 21 | $465 | $22 |
| Novofine 32 | 11 | $454 | $41 |
| Quinapril | 19 | $436 | $23 |
| Metoprolol | 89 | $427 | $5 |
| Propylthiouracil | 12 | $412 | $34 |
| Carvedilol | 31 | $387 | $12 |
| Atenolol | 53 | $385 | $7 |
| Benazepril | 49 | $292 | $6 |
| Enalapril Maleate | 20 | $261 | $13 |
| Losartan-Hydrochlorothiazide | 16 | $244 | $15 |
| Lovastatin | 24 | $201 | $8 |
| Clopidogrel | 19 | $197 | $10 |
| Hydralazine | 16 | $187 | $12 |
| Pen Needle | 11 | $182 | $17 |
| Furosemide | 33 | $161 | $5 |
| Isosorbide Mononitrate Er | 11 | $156 | $14 |
| Ibuprofen | 13 | $125 | $10 |
| Pantoprazole | 14 | $113 | $8 |
| Prednisone | 15 | $103 | $7 |
| Clonidine | 15 | $98 | $7 |
| Verapamil | 11 | $82 | $7 |
2013: 112 drugs
| Novolog Flexpen | 516 | $238,591 | $462 |
| Lantus Solostar | 686 | $193,904 | $283 |
| Humalog | 419 | $179,946 | $429 |
| Januvia | 494 | $156,824 | $317 |
| Forteo | 114 | $153,387 | $1,346 |
| Prolia | 128 | $107,466 | $840 |
| Prandin | 126 | $56,515 | $449 |
| Crestor | 237 | $47,581 | $201 |
| Pioglitazone | 350 | $44,877 | $128 |
| Tradjenta | 143 | $41,200 | $288 |
| Lantus | 160 | $40,720 | $255 |
| Onglyza | 130 | $37,464 | $288 |
| Bd Ultra-Fine Pen Needle | 835 | $36,783 | $44 |
| Byetta | 80 | $35,322 | $442 |
| Diovan | 140 | $24,896 | $178 |
| Levemir Flexpen | 91 | $24,268 | $267 |
| Androgel | 41 | $22,615 | $552 |
| Lovaza | 90 | $21,913 | $243 |
| Nateglinide | 167 | $20,300 | $122 |
| Pioglitazone-Metformin | 48 | $18,752 | $391 |
| Victoza 3-Pak | 29 | $18,068 | $623 |
| Cycloset | 50 | $15,102 | $302 |
| Janumet | 53 | $14,998 | $283 |
| Bydureon | 36 | $14,899 | $414 |
| Repaglinide | 31 | $13,553 | $437 |
| Novolog | 44 | $13,382 | $304 |
| Zemplar | 35 | $12,287 | $351 |
| Apidra | 12 | $11,841 | $987 |
| Zetia | 67 | $11,176 | $167 |
| Humulin R | 14 | $9,969 | $712 |
| Actonel | 48 | $9,574 | $199 |
| Welchol | 31 | $9,465 | $305 |
| Atelvia | 54 | $9,195 | $170 |
| Invokana | 22 | $7,902 | $359 |
| Synthroid | 278 | $7,868 | $28 |
| Metformin Hcl Er | 56 | $7,842 | $140 |
| Niaspan | 47 | $7,775 | $165 |
| Levothyroxine | 929 | $7,742 | $8 |
| Atorvastatin | 290 | $7,523 | $26 |
| Actos | 18 | $7,393 | $411 |
| Symlinpen 120 | 12 | $6,314 | $526 |
| Symlinpen 60 | 11 | $6,277 | $571 |
| Valsartan-Hydrochlorothiazide | 71 | $6,112 | $86 |
| Novolog Mix 70-30 Flexpen | 11 | $5,895 | $536 |
| Cabergoline | 18 | $5,877 | $327 |
| Metformin | 553 | $5,852 | $11 |
| Kombiglyze Xr | 23 | $5,816 | $253 |
| Victoza 2-Pak | 15 | $5,589 | $373 |
| Fenofibrate | 37 | $5,007 | $135 |
| Trilipix | 29 | $4,818 | $166 |
| Diovan Hct | 23 | $4,008 | $174 |
| Exforge | 15 | $3,800 | $253 |
| Alendronate | 325 | $3,436 | $11 |
| Sure Comfort | 91 | $3,365 | $37 |
| Ulticare | 108 | $3,105 | $29 |
| Micardis Hct | 14 | $2,952 | $211 |
| Lidoderm | 11 | $2,881 | $262 |
| Micardis | 15 | $2,799 | $187 |
| Simvastatin | 308 | $2,787 | $9 |
| Hydrocortisone | 72 | $2,739 | $38 |
| Desmopressin Acetate | 12 | $2,683 | $224 |
| Methimazole | 213 | $2,672 | $13 |
| Losartan | 207 | $2,632 | $13 |
| Amlodipine Besylate | 203 | $2,511 | $12 |
| Lyrica | 11 | $2,430 | $221 |
| Calcitriol | 54 | $2,428 | $45 |
| Benicar | 14 | $2,178 | $156 |
| Tribenzor | 13 | $2,163 | $166 |
| Fenofibric Acid | 15 | $2,008 | $134 |
| Bystolic | 17 | $1,878 | $110 |
| Glucagon Emergency Kit | 12 | $1,875 | $156 |
| Tirosint | 28 | $1,842 | $66 |
| Ibandronate | 13 | $1,780 | $137 |
| Advicor | 11 | $1,672 | $152 |
| Lisinopril | 188 | $1,443 | $8 |
| Hydrochlorothiazide | 155 | $1,296 | $8 |
| Glyburide | 39 | $1,246 | $32 |
| Omeprazole | 79 | $1,189 | $15 |
| Glipizide | 143 | $1,119 | $8 |
| Metoprolol | 32 | $1,091 | $34 |
| Fenofibrate | 15 | $1,037 | $69 |
| Glimepiride | 89 | $1,019 | $11 |
| Insulin | 38 | $986 | $26 |
| Pravastatin | 55 | $919 | $17 |
| Clopidogrel | 12 | $810 | $67 |
| Losartan-Hydrochlorothiazide | 35 | $655 | $19 |
| Novofine 32 | 16 | $635 | $40 |
| Amlodipine Besylate-Benazepril | 12 | $624 | $52 |
| Mini Ultra-Thin II | 14 | $572 | $41 |
| Ramipril | 39 | $569 | $15 |
| Glipizide Er | 13 | $517 | $40 |
| Nifedipine Er | 11 | $498 | $45 |
| Insulin | 17 | $496 | $29 |
| Gabapentin | 23 | $450 | $20 |
| Isosorbide Mononitrate Er | 13 | $392 | $30 |
| Atenolol | 51 | $364 | $7 |
| Carvedilol | 30 | $356 | $12 |
| Propylthiouracil | 14 | $343 | $25 |
| Fosinopril | 33 | $332 | $10 |
| Unifine Pentips | 11 | $326 | $30 |
| Clickfine | 15 | $308 | $21 |
| Levoxyl | 23 | $297 | $13 |
| Metoprolol | 49 | $284 | $6 |
| Bisoprolol | 13 | $263 | $20 |
| Lovastatin | 24 | $262 | $11 |
| Benazepril | 34 | $254 | $7 |
| Hydralazine | 17 | $246 | $14 |
| Enalapril Maleate | 37 | $233 | $6 |
| Pantoprazole | 13 | $173 | $13 |
| Furosemide | 32 | $171 | $5 |
| Prazosin | 11 | $108 | $10 |
| Naproxen | 12 | $105 | $9 |
Money from drug and device companies
$180,500 in 2025
| 2025 | 41 | 412 | $149,462 | $180,500 |
| 2024 | 35 | 428 | $86,911 | $108,667 |
| 2023 | 33 | 447 | $102,334 | $126,261 |
| 2022 | 31 | 627 | $216,208 | $262,160 |
| 2021 | 30 | 636 | $192,599 | $208,767 |
| 2020 | 33 | 625 | $174,860 | $197,051 |
| 2019 | 27 | 909 | $262,389 | $339,218 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Mounjaro | $51,597 | 85 payments
|
| Novo Nordisk | Ozempic | $37,245 | 53 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $33,009 | 51 payments
|
| Ascendis Pharma Endocrinology | Yorvipath | $23,882 | 21 payments
|
| Sanofi-Aventis U.S. | Tzield | $14,551 | 15 payments
|
| Amgen | Uplizna | $7,331 | 47 payments
|
See all 412 published payments
| Ascendis Pharma Endocrinology | Travel · 2025-12-20 | Yorvipath | $959 |
| Ascendis Pharma Endocrinology | Meals · 2025-12-19 | Yorvipath | $36 |
| Ascendis Pharma Endocrinology | Meals · 2025-12-18 | Yorvipath | $33 |
| Amgen | Paid to speak or teach · 2025-12-17 | None | $900 |
| Abbott Laboratories | Meals · 2025-12-17 | Freestyle Libre 3 | $20 |
| Abbott Laboratories | Meals · 2025-12-17 | Freestyle Libre 3 | $12 |
| Amgen | Meals · 2025-12-16 | Evenity | $8 |
| Amgen | Meals · 2025-12-16 | Evenity | $16 |
| Dexcom | Meals · 2025-12-16 | Dexcom G6 Transmitter | $32 |
| Novo Nordisk | Meals · 2025-12-14 | Wegovy | $32 |
| Dexcom | Meals · 2025-12-12 | Dexcom G6 Transmitter | $20 |
| Recordati Rare Diseases Inc. | Meals · 2025-12-10 | Isturisa | $26 |
| Recordati Rare Diseases Inc. | Meals · 2025-12-09 | Isturisa | $10 |
| Rhythm Pharmaceuticals | Meals · 2025-12-08 | Imcivree | $18 |
| Mannkind | Meals · 2025-12-08 | Afrezza | $2 |
| Mannkind | Meals · 2025-12-05 | Afrezza | $22 |
| Amgen | Meals · 2025-12-04 | Tepezza | $25 |
| GlaxoSmithKline | Meals · 2025-12-02 | Benlysta | $15 |
| Almatica Pharma | Meals · 2025-12-02 | Teriparatide | $27 |
| Sequel Med Tech | Meals · 2025-12-02 | Twiist | $85 |
| Sequel Med Tech | Meals · 2025-12-02 | Twiist | $34 |
| Madrigal Pharmaceuticals | Meals · 2025-12-01 | Rezdiffra | $25 |
| Amgen | Meals · 2025-11-26 | Evenity | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-25 | Jardiance | $10 |
| Dexcom | Meals · 2025-11-25 | Dexcom G6 Transmitter | $38 |
| Pfizer | Meals · 2025-11-24 | Prevnar 20 | $31 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-11-21 | Kerendia | $2,091 |
| Organon | Meals · 2025-11-21 | None | $32 |
| Alexion Pharmaceuticals | Meals · 2025-11-19 | Strensiq | $35 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-19 | Kerendia | $3 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-19 | Kerendia | $19 |
| Ascendis Pharma Endocrinology | Paid to speak or teach · 2025-11-19 | Yorvipath | $7,358 |
| Abbott Laboratories | Meals · 2025-11-17 | Freestyle Libre 3 | $11 |
| Xeris Pharmaceuticals | Meals · 2025-11-17 | Gvoke Hypopen | $21 |
| Ascendis Pharma Endocrinology | Meals · 2025-11-15 | Yorvipath | $70 |
| Ascendis Pharma Endocrinology | Meals · 2025-11-15 | Yorvipath | $58 |
| Novo Nordisk | Meals · 2025-11-14 | Rybelsus | $19 |
| Ascendis Pharma Endocrinology | Meals · 2025-11-14 | Yorvipath | $16 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-11-13 | Kerendia | $3,834 |
| Recordati Rare Diseases Inc. | Meals · 2025-11-11 | Isturisa | $8 |
| Amgen | Meals · 2025-11-11 | Tepezza | $27 |
| Tandem Diabetes Care | Meals · 2025-11-11 | T:Slim X2 Insulin Pump With Control-Iq | $28 |
| Novo Nordisk | Meals · 2025-11-08 | Wegovy | $25 |
| Dexcom | Meals · 2025-11-07 | Dexcom G6 Transmitter | $23 |
| Amgen | Meals · 2025-11-06 | Tepezza | $29 |
| Novo Nordisk | Meals · 2025-11-04 | Rybelsus | $11 |
| GlaxoSmithKline | Meals · 2025-11-04 | Benlysta | $14 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-11-04 | Kerendia | $1,037 |
| Amgen | Meals · 2025-11-04 | Evenity | $19 |
| Novo Nordisk | Meals · 2025-10-30 | Ozempic | $125 |
| Novo Nordisk | Travel · 2025-10-30 | Ozempic | $804 |
| Novo Nordisk | Paid to speak or teach · 2025-10-30 | Ozempic | $4,534 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-10-30 | Kerendia | $198 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-10-30 | Kerendia | $757 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-29 | Kerendia | $132 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-28 | Jardiance | $10 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-28 | Kerendia | $21 |
| Amgen | Consulting · 2025-10-21 | Uplizna | $1,350 |
| Amgen | Consulting · 2025-10-21 | Uplizna | $2,925 |
| Lilly USA | Meals · 2025-10-15 | Mounjaro | $26 |
| GlaxoSmithKline | Meals · 2025-10-14 | Benlysta | $14 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-14 | Kerendia | $13 |
| Xeris Pharmaceuticals | Meals · 2025-10-14 | Gvoke Hypopen | $20 |
| Dexcom | Meals · 2025-10-10 | Dexcom G6 Transmitter | $15 |
| Novo Nordisk | Paid to speak or teach · 2025-10-09 | Ozempic | $4,534 |
| Novo Nordisk | Meals · 2025-10-09 | Ozempic | $125 |
| Pfizer | Meals · 2025-10-09 | Prevnar 20 | $28 |
| Lilly USA | Meals · 2025-10-07 | Mounjaro | $24 |
| Novo Nordisk | Paid to speak or teach · 2025-10-07 | Ozempic | $494 |
| Novo Nordisk | Meals · 2025-10-07 | Rybelsus | $15 |
| Xeris Pharmaceuticals | Meals · 2025-10-06 | Keveyis | $17 |
| Alexion Pharmaceuticals | Meals · 2025-10-01 | Strensiq | $24 |
| Chiesi USA | Meals · 2025-10-01 | Mycapssa | $22 |
| Abbott Laboratories | Meals · 2025-09-30 | Freestyle Libre 3 | $20 |
| Dexcom | Meals · 2025-09-30 | Dexcom G6 Transmitter | $20 |
| Novo Nordisk | Meals · 2025-09-29 | Wegovy | $32 |
| GlaxoSmithKline | Meals · 2025-09-29 | Benlysta | $14 |
| Amgen | Meals · 2025-09-26 | Tepezza | $66 |
| Amgen | Travel · 2025-09-25 | Tepezza | $580 |
| Amgen | Travel · 2025-09-25 | Tepezza | $234 |
| Amgen | Travel · 2025-09-25 | Tepezza | $503 |
| Ascendis Pharma Endocrinology | Paid to speak or teach · 2025-09-24 | Yorvipath | $2,547 |
| Antares Pharma | Meals · 2025-09-23 | Xyosted | $14 |
| Novo Nordisk | Paid to speak or teach · 2025-09-22 | Ozempic | $930 |
| Recordati Rare Diseases Inc. | Meals · 2025-09-19 | Isturisa | $17 |
| Amgen | Meals · 2025-09-19 | Tepezza | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-18 | Kerendia | $2 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-18 | Kerendia | $15 |
| Sanofi-Aventis U.S. | Meals · 2025-09-18 | Tzield | $122 |
| Sanofi-Aventis U.S. | Paid to speak or teach · 2025-09-18 | Tzield | $3,465 |
| Sanofi-Aventis U.S. | Travel · 2025-09-18 | Tzield | $930 |
| Xeris Pharmaceuticals | Meals · 2025-09-17 | Gvoke Hypopen | $21 |
| Lilly USA | Meals · 2025-09-16 | Mounjaro | $26 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-16 | Jardiance | $9 |
| Lilly USA | Meals · 2025-09-15 | Mounjaro | $25 |
| Verity Pharmaceuticals | Meals · 2025-09-15 | Tlando | $20 |
| Lilly USA | Meals · 2025-09-12 | Mounjaro | $11 |
| Abbott Laboratories | Meals · 2025-09-12 | Freestyle Libre 3 | $12 |
| Ascendis Pharma Endocrinology | Meals · 2025-09-11 | Yorvipath | $11 |
| Madrigal Pharmaceuticals | Meals · 2025-09-11 | Rezdiffra | $28 |
| Ascendis Pharma Endocrinology | Meals · 2025-09-10 | Yorvipath | $28 |
| Ascendis Pharma Endocrinology | Paid to speak or teach · 2025-09-05 | None | $1,415 |
| Tempus AI | Meals · 2025-09-05 | Xt Cdx | $24 |
| Amgen | Meals · 2025-09-03 | Tepezza | $16 |
| Novartis Pharmaceuticals | Meals · 2025-09-02 | Leqvio | $24 |
| Novartis Pharmaceuticals | Meals · 2025-09-02 | Leqvio | $24 |
| Recordati Rare Diseases Inc. | Meals · 2025-08-29 | Isturisa | $19 |
| Almatica Pharma | Meals · 2025-08-28 | Teriparatide | $24 |
| Novo Nordisk | Meals · 2025-08-27 | Wegovy | $30 |
| Amgen | Meals · 2025-08-27 | Repatha | $30 |
| Genzyme | Meals · 2025-08-27 | Tzield | $112 |
| Genzyme | Paid to speak or teach · 2025-08-27 | Tzield | $5,597 |
| Genzyme | Travel · 2025-08-27 | Tzield | $1,316 |
| Dexcom | Meals · 2025-08-27 | Dexcom G6 Transmitter | $29 |
| Ucb | Meals · 2025-08-26 | Bimzelx | $25 |
| Abbott Laboratories | Meals · 2025-08-26 | Freestyle Libre 3 | $19 |
| Madrigal Pharmaceuticals | Meals · 2025-08-22 | Rezdiffra | $22 |
| Amgen | Meals · 2025-08-21 | Tepezza | $30 |
| Sanofi-Aventis U.S. | Meals · 2025-08-21 | Tzield | $118 |
| Sanofi-Aventis U.S. | Paid to speak or teach · 2025-08-21 | Tzield | $4,531 |
| Novo Nordisk | Meals · 2025-08-20 | Rybelsus | $20 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-20 | Kerendia | $2 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-20 | Kerendia | $17 |
| Lilly USA | Meals · 2025-08-19 | Mounjaro | $25 |
| GlaxoSmithKline | Meals · 2025-08-19 | Benlysta | $14 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-19 | Jardiance | $10 |
| Amgen | Meals · 2025-08-19 | Evenity | $37 |
| Amgen | Meals · 2025-08-18 | Otezla | $12 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-08-17 | Kerendia | $275 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-17 | Kerendia | $66 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-17 | Kerendia | $115 |
| Dexcom | Meals · 2025-08-15 | Dexcom G6 Transmitter | $23 |
| Novo Nordisk | Meals · 2025-08-13 | Rybelsus | $27 |
| Lilly USA | Meals · 2025-08-12 | Mounjaro | $9 |
| Amgen | Meals · 2025-08-12 | Repatha | $10 |
| Abbott Laboratories | Meals · 2025-08-12 | Freestyle Libre 3 | $19 |
| Novo Nordisk | Meals · 2025-08-05 | Rybelsus | $11 |
| Bayer Healthcare Pharmaceuticals | Education · 2025-08-05 | Kerendia | $20 |
| Sanofi-Aventis U.S. | Meals · 2025-08-05 | Tzield | $30 |
| Ascendis Pharma Endocrinology | Paid to speak or teach · 2025-08-01 | Yorvipath | $3,396 |
| Ascendis Pharma Endocrinology | Paid to speak or teach · 2025-08-01 | Yorvipath | $2,547 |
| Recordati Rare Diseases Inc. | Meals · 2025-07-31 | Isturisa | $20 |
| Novo Nordisk | Meals · 2025-07-31 | Rybelsus | $9 |
| Ascendis Pharma Endocrinology | Meals · 2025-07-31 | Yorvipath | $109 |
| Lilly USA | Meals · 2025-07-30 | Mounjaro | $25 |
| Novo Nordisk | Paid to speak or teach · 2025-07-30 | Ozempic | $2,093 |
| Novo Nordisk | Meals · 2025-07-30 | Ozempic | $125 |
| Lilly USA | Meals · 2025-07-29 | Mounjaro | $26 |
| Amgen | Meals · 2025-07-28 | Tepezza | $21 |
| Ascendis Pharma Endocrinology | Travel · 2025-07-25 | Yorvipath | $1,021 |
| Ascendis Pharma Endocrinology | Travel · 2025-07-25 | Yorvipath | $1,021 |
| Alexion Pharmaceuticals | Meals · 2025-07-24 | Strensiq | $33 |
| Ascendis Pharma Endocrinology | Meals · 2025-07-24 | Yorvipath | $44 |
| Madrigal Pharmaceuticals | Meals · 2025-07-24 | Rezdiffra | $150 |
| Ascendis Pharma Endocrinology | Paid to speak or teach · 2025-07-23 | Yorvipath | $1,698 |
| Ascendis Pharma Endocrinology | Paid to speak or teach · 2025-07-23 | Yorvipath | $1,415 |
| Radius Health | Meals · 2025-07-23 | None | $29 |
| Xeris Pharmaceuticals | Meals · 2025-07-22 | Gvoke Hypopen | $25 |
| Pfizer | Meals · 2025-07-21 | Prevnar 20 | $24 |
| Novo Nordisk | Meals · 2025-07-19 | Wegovy | $1 |
| Novo Nordisk | Meals · 2025-07-19 | Wegovy | $2 |
| Novo Nordisk | Meals · 2025-07-19 | Wegovy | $8 |
| Sanofi-Aventis U.S. | Meals · 2025-07-17 | Tzield | $125 |
| Sanofi-Aventis U.S. | Paid to speak or teach · 2025-07-17 | Tzield | $2,932 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-07-16 | Kerendia | $420 |
| Madrigal Pharmaceuticals | Meals · 2025-07-16 | Rezdiffra | $26 |
| Sanofi-Aventis U.S. | Meals · 2025-07-12 | Tzield | $100 |
| Verity Pharmaceuticals | Meals · 2025-07-11 | Tlando | $15 |
| Aurinia Pharma U.S. | Meals · 2025-07-10 | Lupkynis | $27 |
| Lilly USA | Meals · 2025-07-09 | Mounjaro | $4 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-07-09 | Kerendia | $22 |
| GlaxoSmithKline | Meals · 2025-07-08 | Benlysta | $14 |
| Abbvie | Meals · 2025-07-08 | Synthroid | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-08 | Jardiance | $9 |
| Sanofi-Aventis U.S. | Meals · 2025-07-08 | Tzield | $10 |
| Amgen | Meals · 2025-07-03 | Evenity | $29 |
| Ionis Pharmaceuticals | Meals · 2025-07-01 | Tryngolza | $22 |
| Lilly USA | Paid to speak or teach · 2025-06-30 | Mounjaro | $1,400 |
| Lilly USA | Paid to speak or teach · 2025-06-30 | Mounjaro | $1,400 |
| Lilly USA | Paid to speak or teach · 2025-06-30 | Mounjaro | $1,225 |
| Almatica Pharma | Meals · 2025-06-30 | Teriparatide | $21 |
| Lilly USA | Paid to speak or teach · 2025-06-27 | Mounjaro | $1,225 |
| Lilly USA | Paid to speak or teach · 2025-06-27 | Mounjaro | $1,400 |
| Dexcom | Meals · 2025-06-27 | Dexcom G6 Transmitter | $22 |
| Lilly USA | Meals · 2025-06-25 | Mounjaro | $30 |
| Lilly USA | Meals · 2025-06-25 | Mounjaro | $125 |
| Lilly USA | Travel · 2025-06-24 | None | $443 |
| Lilly USA | Meals · 2025-06-24 | Mounjaro | $125 |
| Lilly USA | Meals · 2025-06-24 | Zepbound | $20 |
| Lilly USA | Travel · 2025-06-24 | None | $604 |
| Amgen | Meals · 2025-06-24 | Repatha | $6 |
| Abbott Laboratories | Meals · 2025-06-24 | Freestyle Libre 3 | $8 |
| Verity Pharmaceuticals | Meals · 2025-06-20 | Tlando | $15 |
| Amgen | Meals · 2025-06-19 | Evenity | $32 |
| Madrigal Pharmaceuticals | Meals · 2025-06-19 | Rezdiffra | $21 |
| Amgen | Meals · 2025-06-18 | Repatha | $6 |
| Novo Nordisk | Meals · 2025-06-16 | Rybelsus | $20 |
| Novo Nordisk | Meals · 2025-06-14 | Wegovy | $32 |
| IBSA Pharma | Meals · 2025-06-12 | Tirosint | $17 |
| Amgen | Meals · 2025-06-11 | Tepezza | $17 |
| Novo Nordisk | Travel · 2025-06-10 | Ozempic | $1,068 |
| Novo Nordisk | Paid to speak or teach · 2025-06-10 | Ozempic | $3,604 |
| Novo Nordisk | Meals · 2025-06-10 | Ozempic | $103 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-10 | Jardiance | $13 |
| Chiesi USA | Meals · 2025-06-04 | Mycapssa | $23 |
| Radius Health | Meals · 2025-06-04 | None | $25 |
| GlaxoSmithKline | Meals · 2025-06-03 | Benlysta | $15 |
| Mannkind | Meals · 2025-06-03 | Afrezza | $35 |
| Mannkind | Meals · 2025-05-30 | Afrezza | $29 |
| Lilly USA | Meals · 2025-05-28 | Mounjaro | $23 |
| Novo Nordisk | Paid to speak or teach · 2025-05-28 | Ozempic | $2,093 |
| Novo Nordisk | Meals · 2025-05-28 | Ozempic | $125 |
| Novo Nordisk | Meals · 2025-05-27 | Ozempic | $9 |
| Xeris Pharmaceuticals | Meals · 2025-05-27 | Recorlev | $25 |
| Novo Nordisk | Meals · 2025-05-23 | Ozempic | $24 |
| Abbott Laboratories | Meals · 2025-05-23 | Freestyle Libre 3 | $20 |
| Madrigal Pharmaceuticals | Meals · 2025-05-22 | Rezdiffra | $23 |
| Novo Nordisk | Meals · 2025-05-21 | Ozempic | $32 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-05-21 | Kerendia | $3,834 |
| Sanofi-Aventis U.S. | Meals · 2025-05-21 | Tzield | $21 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-05-20 | Kerendia | $954 |
| Amgen | Meals · 2025-05-19 | Otezla | $10 |
| Mannkind | Meals · 2025-05-19 | Afrezza | $7 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-17 | Kerendia | $3 |
| Lilly USA | Paid to speak or teach · 2025-05-16 | Mounjaro | $700 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-16 | Kerendia | $1 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-16 | Kerendia | $12 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-05-16 | Kerendia | $3,834 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-05-16 | Kerendia | $2,091 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-15 | Kerendia | $85 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-05-15 | Kerendia | $805 |
| Pfizer | Meals · 2025-05-14 | Prevnar 20 | $29 |
| Madrigal Pharmaceuticals | Meals · 2025-05-14 | Rezdiffra | $24 |
| Lilly USA | Paid to speak or teach · 2025-05-13 | Mounjaro | $1,400 |
| Lilly USA | Paid to speak or teach · 2025-05-13 | Mounjaro | $875 |
| Novo Nordisk | Meals · 2025-05-13 | Ozempic | $10 |
| Novartis Pharmaceuticals | Meals · 2025-05-13 | Leqvio | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-13 | Jardiance | $9 |
| GlaxoSmithKline | Meals · 2025-05-12 | Benlysta | $15 |
| Amgen | Meals · 2025-05-12 | Evenity | $5 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-10 | Kerendia | $122 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-05-10 | Kerendia | $225 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-09 | Kerendia | $30 |
| Lilly USA | Travel · 2025-05-07 | None | $198 |
| Lilly USA | Travel · 2025-05-07 | None | $835 |
| Amgen | Meals · 2025-05-07 | Tepezza | $24 |
| Novo Nordisk | Meals · 2025-05-06 | Ozempic | $125 |
| Novo Nordisk | Paid to speak or teach · 2025-05-06 | Ozempic | $2,093 |
| Sanofi-Aventis U.S. | Meals · 2025-05-06 | Tzield | $8 |
| Lilly USA | Paid to speak or teach · 2025-05-05 | Mounjaro | $1,400 |
| Lilly USA | Paid to speak or teach · 2025-05-05 | Mounjaro | $1,225 |
| Novo Nordisk | Meals · 2025-05-05 | Rybelsus | $20 |
| Novo Nordisk | Meals · 2025-05-03 | Wegovy | $19 |
| Lilly USA | Paid to speak or teach · 2025-05-01 | Mounjaro | $700 |
| Novo Nordisk | Meals · 2025-05-01 | Ozempic | $23 |
| Lilly USA | Travel · 2025-04-30 | None | $350 |
| Lilly USA | Meals · 2025-04-30 | Mounjaro | $122 |
| Amgen | Meals · 2025-04-30 | Evenity | $14 |
| Recordati Rare Diseases Inc. | Meals · 2025-04-29 | Signifor Lar | $26 |
| Abbvie | Meals · 2025-04-29 | Synthroid | $15 |
| Boehringer Ingelheim Pharmaceuticals | Paid to speak or teach · 2025-04-29 | Jardiance | $1,150 |
| Esperion Therapeutics | Meals · 2025-04-29 | Nexletol | $20 |
| Lilly USA | Paid to speak or teach · 2025-04-28 | Mounjaro | $1,400 |
| Lilly USA | Paid to speak or teach · 2025-04-28 | Mounjaro | $1,225 |
| Lilly USA | Paid to speak or teach · 2025-04-28 | Mounjaro | $700 |
| Lilly USA | Paid to speak or teach · 2025-04-28 | Mounjaro | $1,400 |
| Amgen | Education · 2025-04-25 | Tepezza | $10 |
| Amgen | Meals · 2025-04-25 | Tepezza | $26 |
| Lilly USA | Travel · 2025-04-24 | None | $352 |
| Lilly USA | Travel · 2025-04-24 | None | $211 |
| Lilly USA | Meals · 2025-04-24 | Mounjaro | $125 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-24 | Kerendia | $16 |
| Amgen | Meals · 2025-04-24 | Evenity | $13 |
| Novo Nordisk | Paid to speak or teach · 2025-04-23 | Ozempic | $3,023 |
| Alexion Pharmaceuticals | Meals · 2025-04-23 | Strensiq | $30 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-23 | Kerendia | $2 |
| Pfizer | Meals · 2025-04-23 | Prevnar 20 | $26 |
| Lilly USA | Meals · 2025-04-22 | Mounjaro | $24 |
| GlaxoSmithKline | Meals · 2025-04-21 | Benlysta | $15 |
| Amgen | Meals · 2025-04-21 | Otezla | $12 |
| Recordati Rare Diseases Inc. | Meals · 2025-04-18 | Isturisa | $18 |
| Lilly USA | Paid to speak or teach · 2025-04-18 | Mounjaro | $1,400 |
| Lilly USA | Paid to speak or teach · 2025-04-18 | Jardiance | $500 |
| Lilly USA | Paid to speak or teach · 2025-04-18 | Mounjaro | $1,225 |
| Lilly USA | Paid to speak or teach · 2025-04-18 | Jardiance | $1,300 |
| Xeris Pharmaceuticals | Meals · 2025-04-18 | Recorlev | $21 |
| Pfizer | Meals · 2025-04-17 | Paxlovid | $18 |
| Lilly USA | Travel · 2025-04-16 | None | $350 |
| Lilly USA | Travel · 2025-04-16 | None | $430 |
| Lilly USA | Paid to speak or teach · 2025-04-16 | Mounjaro | $700 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-15 | Jardiance | $7 |
| Ascendis Pharma Endocrinology | Meals · 2025-04-14 | Yorvipath | $84 |
| Amgen | Meals · 2025-04-11 | Evenity | $16 |
| Amgen | Meals · 2025-04-11 | Evenity | $21 |
| Lilly USA | Paid to speak or teach · 2025-04-10 | Mounjaro | $700 |
| Lilly USA | Paid to speak or teach · 2025-04-10 | Mounjaro | $1,400 |
| Lilly USA | Meals · 2025-04-10 | Jardiance | $125 |
| Lilly USA | Paid to speak or teach · 2025-04-10 | Mounjaro | $1,225 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-09 | Jardiance | $21 |
| Lilly USA | Paid to speak or teach · 2025-04-08 | Mounjaro | $700 |
| Lilly USA | Meals · 2025-04-08 | Mounjaro | $121 |
| Lilly USA | Travel · 2025-04-08 | None | $350 |
| Amgen | Meals · 2025-04-08 | Evenity | $17 |
| Abbott Laboratories | Meals · 2025-04-02 | Freestyle Libre 3 | $22 |
| Novo Nordisk | Paid to speak or teach · 2025-04-01 | Ozempic | $3,023 |
| Novo Nordisk | Meals · 2025-04-01 | Ozempic | $125 |
| Novo Nordisk | Meals · 2025-04-01 | Ozempic | $6 |
| Amgen | Meals · 2025-04-01 | Repatha | $24 |
| Neurocrine BioSciences | Meals · 2025-04-01 | Crenessity | $20 |
| Lilly USA | Paid to speak or teach · 2025-03-31 | Mounjaro | $1,400 |
| Lilly USA | Paid to speak or teach · 2025-03-31 | Mounjaro | $1,225 |
| Lilly USA | Paid to speak or teach · 2025-03-31 | Mounjaro | $700 |
| Lilly USA | Paid to speak or teach · 2025-03-28 | Mounjaro | $1,400 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-27 | Kerendia | $15 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-27 | Kerendia | $2 |
| Sanofi-Aventis U.S. | Paid to speak or teach · 2025-03-27 | Tzield | $2,132 |
| Abbott Laboratories | Meals · 2025-03-26 | Freestyle Libre 3 | $11 |
| Mannkind | Meals · 2025-03-26 | Afrezza | $14 |
| Lilly USA | Travel · 2025-03-25 | None | $350 |
| Lilly USA | Paid to speak or teach · 2025-03-25 | Mounjaro | $1,400 |
| Lilly USA | Paid to speak or teach · 2025-03-25 | Mounjaro | $1,225 |
| Lilly USA | Meals · 2025-03-25 | Mounjaro | $29 |
| Lilly USA | Meals · 2025-03-25 | Mounjaro | $1 |
| Lilly USA | Meals · 2025-03-25 | Mounjaro | $124 |
| Lilly USA | Meals · 2025-03-25 | Mounjaro | $21 |
| Lilly USA | Travel · 2025-03-25 | None | $201 |
| Lilly USA | Travel · 2025-03-25 | None | $149 |
| GlaxoSmithKline | Meals · 2025-03-25 | Benlysta | $15 |
| Lilly USA | Travel · 2025-03-20 | None | $248 |
| Lilly USA | Meals · 2025-03-20 | Mounjaro | $120 |
| Lilly USA | Paid to speak or teach · 2025-03-20 | Mounjaro | $1,225 |
| Lilly USA | Paid to speak or teach · 2025-03-20 | Mounjaro | $1,400 |
| Lilly USA | Travel · 2025-03-20 | None | $350 |
| Ascendis Pharma Endocrinology | Meals · 2025-03-19 | Yorvipath | $16 |
| Lilly USA | Paid to speak or teach · 2025-03-18 | Mounjaro | $700 |
| Lilly USA | Travel · 2025-03-18 | None | $350 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-18 | Jardiance | $6 |
| Xeris Pharmaceuticals | Meals · 2025-03-17 | Gvoke Hypopen | $19 |
| Lilly USA | Meals · 2025-03-12 | Jardiance | $23 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-03-12 | Kerendia | $455 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-12 | Kerendia | $37 |
| Amgen | Meals · 2025-03-12 | Tepezza | $13 |
| Lilly USA | Paid to speak or teach · 2025-03-10 | Jardiance | $894 |
| Novo Nordisk | Travel · 2025-03-08 | Ozempic | $121 |
| Novo Nordisk | Travel · 2025-03-08 | Ozempic | $399 |
| Novo Nordisk | Travel · 2025-03-08 | Ozempic | $771 |
| Novo Nordisk | Paid to speak or teach · 2025-03-08 | Ozempic | $6,004 |
| Novo Nordisk | Meals · 2025-03-08 | Ozempic | $298 |
| Lilly USA | Paid to speak or teach · 2025-03-07 | Mounjaro | $700 |
| Novo Nordisk | Meals · 2025-03-05 | Ozempic | $9 |
| Sanofi Pasteur | Meals · 2025-03-05 | None | $30 |
| Lilly USA | Paid to speak or teach · 2025-03-03 | Jardiance | $650 |
| Lilly USA | Paid to speak or teach · 2025-03-03 | Jardiance | $500 |
| Almatica Pharma | Meals · 2025-03-03 | Teriparatide | $23 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-02-28 | Kerendia | $2,788 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-28 | Kerendia | $34 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-02-28 | Kerendia | $455 |
| Mannkind | Meals · 2025-02-28 | Afrezza | $2 |
| Mannkind | Meals · 2025-02-27 | Afrezza | $19 |
| Amgen | Meals · 2025-02-26 | Tepezza | $17 |
| Amgen | Meals · 2025-02-25 | Tepezza | $34 |
| Neurocrine BioSciences | Meals · 2025-02-25 | Crenessity | $21 |
| Neurocrine BioSciences | Education · 2025-02-24 | Crenessity | $24 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-02-21 | Kerendia | $3,834 |
| Radius Health | Meals · 2025-02-21 | None | $19 |
| Amgen | Meals · 2025-02-20 | Evenity | $32 |
| Amgen | Meals · 2025-02-19 | Evenity | $24 |
| Sanofi-Aventis U.S. | Meals · 2025-02-19 | Tzield | $16 |
| Novo Nordisk | Meals · 2025-02-18 | Ozempic | $15 |
| GlaxoSmithKline | Meals · 2025-02-18 | Benlysta | $15 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-18 | Jardiance | $13 |
| Mannkind | Meals · 2025-02-18 | Afrezza | $23 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-02-16 | Kerendia | $156 |
| Lilly USA | Paid to speak or teach · 2025-02-14 | Mounjaro | $2,800 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-14 | Kerendia | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-14 | Kerendia | $2 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-14 | Kerendia | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-14 | Kerendia | $105 |
| Lilly USA | Paid to speak or teach · 2025-02-13 | Mounjaro | $700 |
| Seqirus USA | Meals · 2025-02-12 | Fluad | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-12 | Kerendia | $1 |
| Mannkind | Education · 2025-02-12 | Afrezza | $43 |
| Lilly USA | Meals · 2025-02-11 | Mounjaro | $22 |
| Pfizer | Meals · 2025-02-10 | Somavert | $7 |
| Beta Bionics | Meals · 2025-02-08 | Ilet Bionic Pancreas | $25 |
| Beta Bionics | Meals · 2025-02-08 | Ilet Bionic Pancreas | $43 |
| Abbott Laboratories | Meals · 2025-02-07 | Freestyle Libre 3 | $20 |
| Lilly USA | Travel · 2025-02-06 | None | $248 |
| Lilly USA | Travel · 2025-02-06 | None | $430 |
| Amgen | Meals · 2025-02-04 | Evenity | $27 |
| Sanofi-Aventis U.S. | Meals · 2025-02-04 | Tzield | $13 |
| Ascensia Diabetes Care Us | Meals · 2025-02-01 | None | $24 |
| Kyowa Kirin | Meals · 2025-01-29 | Crysvita | $26 |
| Radius Health | Meals · 2025-01-24 | None | $21 |
| Alexion Pharmaceuticals | Meals · 2025-01-22 | Strensiq | $31 |
| Lilly USA | Meals · 2025-01-21 | Mounjaro | $20 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-01-18 | Kerendia | $3,834 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-18 | Kerendia | $113 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-18 | Kerendia | $66 |
| IBSA Pharma | Meals · 2025-01-17 | Tirosint | $19 |
| Novo Nordisk | Meals · 2025-01-14 | Ozempic | $10 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-14 | Jardiance | $7 |
| Abbott Laboratories | Meals · 2025-01-14 | Freestyle Libre 3 | $9 |
| GlaxoSmithKline | Meals · 2025-01-13 | Benlysta | $14 |
| Amgen | Meals · 2025-01-13 | Enbrel | $18 |
| Mannkind | Meals · 2025-01-10 | Afrezza | $24 |
| Novo Nordisk | Meals · 2025-01-08 | Ozempic | $25 |
| Novo Nordisk | Meals · 2025-01-07 | Ozempic | $9 |
| Mannkind | Paid to speak or teach · 2025-01-07 | Afrezza | $1,800 |
| Xeris Pharmaceuticals | Meals · 2025-01-06 | Gvoke Hypopen | $22 |
| ANI Pharmaceuticals | Meals · 2025-01-04 | Purified Cortrophin Gel | $16 |
| Amgen | Meals · 2025-01-02 | Tepezza | $4 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $108,667
| Lilly USA | Mounjaro | $54,903 | 138 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $25,944 | 27 payments
|
| Novo Nordisk | Ozempic | $10,694 | 52 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $7,231 | 32 payments
|
| Mannkind | Afrezza | $4,855 | 23 payments
|
| IBSA Pharma | Tirosint | $1,791 | 11 payments
|
| Xeris Pharmaceuticals | Recorlev | $636 | 17 payments
|
| Amgen | Tepezza | $446 | 27 payments
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $196 | 9 payments
|
| Sanofi-Aventis U.S. | Tzield | $177 | 9 payments
|
| GlaxoSmithKline | Benlysta | $167 | 12 payments
|
| Pfizer | Prevnar 20 | $164 | 8 payments
|
| Beta Bionics | Ilet Bionic Pancreas | $161 | 3 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $160 | 12 payments
|
| Ascensia Diabetes Care Us | Eversense E3 Sensor Kit - Retail | $137 | 6 payments
|
| Aurinia Pharma U.S. | Lupkynis | $130 | 5 payments
|
| Recordati Rare Diseases Inc. | Signifor Lar | $128 | 6 payments
|
| Corcept Therapeutics | Korlym | $99 | 1 payment
|
| Verity Pharmaceuticals | Tlando | $75 | 4 payments
|
| Alexion Pharmaceuticals | Strensiq | $73 | 3 payments
|
| Abbvie | Synthroid | $56 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $55 | 3 payments
|
| Almatica Pharma | Teriparatide | $51 | 3 payments
|
| Esperion Therapeutics | Nexletol | $47 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $45 | 2 payments
|
| Radius Health | None | $38 | 2 payments
|
| Averitas Pharma | Qutenza | $34 | 1 payment
|
| Eisai | Lenvima | $29 | 1 payment
|
| Azurity Pharmaceuticals | Horizant | $27 | 1 payment
|
| Sanofi Pasteur | Flublok Quadrivalent Northern Hemisphere | $25 | 1 payment
|
| Kyowa Kirin | Crysvita | $23 | 1 payment
|
| Madrigal Pharmaceuticals | Resmetirom | $19 | 1 payment
|
| Regeneron Healthcare Solutions | Evkeeza | $18 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $17 | 1 payment
|
| Antares Pharma | Xyosted | $13 | 1 payment
|
2023: $126,261
| Lilly USA | Mounjaro | $55,972 | 126 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $28,786 | 34 payments
|
| Novo Nordisk | Rybelsus | $15,139 | 57 payments
|
| Dexcom | Dexcom G7 Gss (161) | $12,416 | 16 payments
|
| MannKind | Afrezza | $6,849 | 33 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $1,670 | 14 payments
|
| IBSA Pharma | Tirosint | $1,527 | 12 payments
|
| Amgen | Repatha | $893 | 15 payments
|
| Sanofi-Aventis U.S. | Tzield | $349 | 8 payments
|
| Horizon Therapeutics plc | Tepezza | $300 | 5 payments
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $294 | 10 payments
|
| Radius Health | Tymlos | $276 | 15 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $261 | 17 payments
|
| Ascensia Diabetes Care Us | None | $195 | 5 payments
|
| GlaxoSmithKline | Benlysta | $178 | 14 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $163 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $151 | 8 payments
|
| Pfizer | Somavert | $129 | 10 payments
|
| Embecta | Bd Nano 2nd Gen Pen Needle | $109 | 5 payments
|
| Corcept Therapeutics | Korlym | $108 | 3 payments
|
| Antares Pharma | Nocdurna | $66 | 4 payments
|
| Alexion Pharmaceuticals | Strensiq | $65 | 3 payments
|
| Recordati Rare Diseases Inc. | Signifor Lar | $60 | 3 payments
|
| Ascendis Pharma | None | $50 | 3 payments
|
| Kyowa Kirin | Crysvita | $42 | 2 payments
|
| Ultragenyx Pharmaceutical | None | $38 | 2 payments
|
| Averitas Pharma | Qutenza | $34 | 1 payment
|
| Esperion Therapeutics | Nexletol | $33 | 2 payments
|
| Eisai | Lenvima | $26 | 1 payment
|
| CeQur | Cequr Simplicity | $26 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $25 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $19 | 1 payment
|
| Supernus Pharmaceuticals | Xyosted | $14 | 1 payment
|
2022: $262,160
| Lilly USA | Mounjaro | $78,905 | 166 payments
|
| Novo Nordisk | Rybelsus | $72,614 | 133 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $63,279 | 74 payments
|
| Corcept Therapeutics | Korlym | $17,421 | 22 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $10,898 | 30 payments
|
| Amgen | Repatha | $6,407 | 15 payments
|
| Dexcom | Dexcom G6 Transmitter | $6,393 | 11 payments
|
| IBSA Pharma | Tirosint | $1,864 | 15 payments
|
| Horizon Therapeutics plc | Tepezza | $1,672 | 32 payments
|
| Mannkind | Afrezza | $560 | 19 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $391 | 12 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $280 | 16 payments
|
| Radius Health | Tymlos | $265 | 16 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $195 | 10 payments
|
| Abbvie | Ubrelvy | $139 | 9 payments
|
| GlaxoSmithKline | Benlysta | $139 | 12 payments
|
| Pfizer | Somavert | $106 | 5 payments
|
| Aurinia Pharma U.S. | Lupkynis | $103 | 4 payments
|
| Alexion Pharmaceuticals | Strensiq | $97 | 5 payments
|
| Merck Sharp & Dohme | Januvia | $74 | 4 payments
|
| Abbott Laboratories | Freestyle Libre 2 | $50 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $49 | 3 payments
|
| TOLMAR Pharmaceuticals | Fensolvi | $39 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $35 | 2 payments
|
| Esperion Therapeutics | Nexletol | $32 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $30 | 2 payments
|
| Amryt Pharma Holdings | Mycapssa | $30 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $28 | 1 payment
|
| Eisai | Lenvima | $25 | 1 payment
|
| Antares Pharma | Nocdurna | $20 | 1 payment
|
| Bigfoot Biomedical | Unity Diabetes Management System | $18 | 1 payment
|
2021: $208,767
| Novo Nordisk | Rybelsus | $77,270 | 155 payments
|
| Lilly USA | Trulicity | $69,913 | 150 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $15,152 | 34 payments
|
| Corcept Therapeutics | Korlym | $10,112 | 28 payments
|
| Sanofi-Aventis U.S. | Toujeo | $9,995 | 21 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $9,993 | 21 payments
|
| MannKind | Afrezza | $5,277 | 37 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $4,756 | 18 payments
|
| Amgen | Repatha | $3,539 | 27 payments
|
| AbbVie | Creon | $438 | 15 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $368 | 14 payments
|
| Radius Health | Tymlos | $313 | 22 payments
|
| Kowa Pharmaceuticals America | Livalo | $275 | 14 payments
|
| Dexcom | Dexcom G6 Transmitter | $227 | 4 payments
|
| Amarin Pharma | Vascepa | $210 | 13 payments
|
| IBSA Pharma | Tirosint | $185 | 10 payments
|
| Zealand Pharma US | Zegalogue | $173 | 11 payments
|
| Merck Sharp & Dohme | Januvia | $155 | 10 payments
|
| Horizon Therapeutics plc | Tepezza | $76 | 4 payments
|
| Alexion Pharmaceuticals | Strensiq | $60 | 3 payments
|
| Ultragenyx Pharmaceutical | Crysvita | $51 | 3 payments
|
| Esperion Therapeutics | Nexletol | $35 | 2 payments
|
| Abbott Laboratories | Freestyle Libre | $34 | 2 payments
|
| ASCEND Therapeutics US | Binosto | $32 | 2 payments
|
| Medtronic | Minimed 670g System | $31 | 2 payments
|
| Recordati Rare Diseases Inc. | None | $25 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $23 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $17 | 1 payment
|
| Insulet | Omnipod | $17 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $16 | 1 payment
|
2020: $197,051
| Lilly USA | Trulicity | $106,002 | 219 payments
|
| Novo Nordisk | Ozempic | $44,244 | 132 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $10,623 | 22 payments
|
| Corcept Therapeutics | Korlym | $9,805 | 20 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $8,788 | 18 payments
|
| Amgen | Repatha | $6,655 | 35 payments
|
| Mannkind | Afrezza | $3,881 | 26 payments
|
| Merck Sharp & Dohme | Steglatro | $3,203 | 16 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $1,845 | 23 payments
|
| Amarin Pharma | Vascepa | $351 | 21 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $263 | 13 payments
|
| Janssen Pharmaceuticals | Invokana | $211 | 10 payments
|
| Abbott Laboratories | Freestyle Lite System | $154 | 2 payments
|
| Radius Health | Tymlos | $150 | 10 payments
|
| AbbVie | Synthroid | $132 | 8 payments
|
| IBSA Pharma | Tirosint | $100 | 6 payments
|
| Kowa Pharmaceuticals America | Livalo | $99 | 6 payments
|
| Arbor Pharmaceuticals | Edarbyclor | $64 | 3 payments
|
| Senseonics | Eversense | $63 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $48 | 3 payments
|
| Janssen Biotech | Remicade | $48 | 3 payments
|
| Horizon Therapeutics plc | Tepezza | $41 | 3 payments
|
| Sun Pharmaceutical Industries | Riomet Er | $40 | 2 payments
|
| Medtronic MiniMed | Minimed 670g System | $39 | 3 payments
|
| Esperion Therapeutics | Nexletol | $36 | 3 payments
|
| Strongbridge US | Keveyis | $30 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $26 | 2 payments
|
| Dexcom | Dexcom G6 Cgm System | $25 | 1 payment
|
| Boston Scientific | General - Pain Management | $24 | 1 payment
|
| Genzyme | Kevzara | $18 | 1 payment
|
| Ultragenyx Pharmaceutical | Cryvista | $16 | 1 payment
|
| Becton Dickinson and | Bd Nano | $16 | 1 payment
|
| LifeScan | Ot Verio Flex Starter Kit | $14 | 1 payment
|
2019: $339,218
| Lilly USA | Trulicity | $148,843 | 380 payments
|
| Novo Nordisk | Ozempic | $56,893 | 136 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $49,247 | 78 payments
|
| Sanofi-Aventis U.S. | Toujeo | $25,479 | 49 payments
|
| Janssen Pharmaceuticals | Invokana | $15,007 | 42 payments
|
| Merck Sharp & Dohme | Steglatro | $12,236 | 32 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $11,540 | 21 payments
|
| Amgen | Repatha | $8,366 | 23 payments
|
| Mannkind | Afrezza | $4,576 | 29 payments
|
| Regeneron Healthcare Solutions | Praluent | $3,063 | 13 payments
|
| Corcept Therapeutics | Korlym | $2,707 | 11 payments
|
| Amarin Pharma | Vascepa | $359 | 33 payments
|
| AbbVie | Synthroid | $201 | 13 payments
|
| Shire North American Group | Natpara (Parathyroid Hormone) | $143 | 9 payments
|
| Abbott Laboratories | Freestyle Libre Pro | $125 | 12 payments
|
| IBSA Pharma | Tirosint | $62 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $58 | 3 payments
|
| Dexcom | Dexcom Cgm | $50 | 2 payments
|
| Insulet | Omnipod | $50 | 3 payments
|
| Radius Health | Tymlos | $42 | 2 payments
|
| Senseonics | Eversense | $38 | 2 payments
|
| Arbor Pharmaceuticals | Edarbi | $32 | 2 payments
|
| Antares Pharma | Xyosted | $25 | 2 payments
|
| Boston Scientific | General Therapies | $24 | 1 payment
|
| Aytu BioScience | Natesto | $20 | 1 payment
|
| Sanofi Pasteur | Fluzone High-Dose | $17 | 1 payment
|
| Eisai | Lenvima | $14 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Eli Lilly and Company · A Randomized, Double-Blind Study With An Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (Award-Peds: Assessment of Weekly Administration of Ly2189265 in Diabetes-Pediatric Study) · 2020 | This clinician | $22,086 |
| Eli Lilly and Company · A Randomized, Double-Blind Study With An Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (Award-Peds: Assessment of Weekly Administration of Ly2189265 in Diabetes-Pediatric Study) · 2021 | This clinician | $10,916 |
| Novo Nordisk AS · Ozempic · 2019 | This clinician | $7,840 |
| Novo Nordisk AS · Ozempic · 2020 | This clinician | $5,548 |
| Eli Lilly and Company · A Randomized, Double-Blind Study With An Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (Award-Peds: Assessment of Weekly Administration of Ly2189265 in Diabetes-Pediatric Study) · 2022 | Their institution | $3,803 |
| Eli Lilly and Company · A Randomized, Double-Blind Study With An Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus-Award-Peds- Assessment of Weekly Administration of Ly2189265 in Diabetes-Pediatric Study · 2019 | This clinician | $3,143 |
| Novo Nordisk AS · Ozempic · 2021 | This clinician | $2,340 |
| Novo Nordisk AS · Ozempic · 2022 | Their institution | $1,460 |
| Eli Lilly and Company · A Randomized, Double-Blind Study With An Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (Award-Peds: Assessment of Weekly Administration of Ly2189265 in Diabetes-Pediatric Study) · 2021 | Their institution | $398 |
| Eli Lilly and Company · A Randomized, Double-Blind Study With An Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus-Award-Peds- Assessment of Weekly Administration of Ly2189265 in Diabetes-Pediatric Study · 2019 | Their institution | $339 |
| Eli Lilly and Company · A Randomized, Double-Blind Study With An Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (Award-Peds: Assessment of Weekly Administration of Ly2189265 in Diabetes-Pediatric Study) · 2022 | This clinician | $220 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1801813720
- Licence
- CA A78885California A78885: Current · expires 2028-05-31
- Trained
- University of Virginia School of Medicine, 1999
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 2690 S White Rd, Suite 50, San Jose, CA, 95148
- NPI first listed
- 2006-07-16
- NPI last updated
- 2023-11-11
- NPI record certified
- 2023-11-11
This is when the NPI record was last certified, not a medical board exam.